{"study_id": 110412, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of arachidonic acid in the biosynthesis of leukotrienes (LTs) and their bioactivities in allergy and inflammation.", "results_summary": "The study found that arachidonic acid is a precursor for leukotrienes, which are involved in allergy and inflammation, primarily through the action of 5-lipoxygenase (5-LO) and its activating protein (FLAP).", "population_specificity": "Not specified (general biological mechanism study)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:34.128288+00:00"}
{"study_id": 110410, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dipyrone interferes with the platelet-inhibiting effects of low-dose aspirin, focusing on arachidonic acid-induced aggregation and thromboxane formation.", "results_summary": "The study found that dipyrone significantly reduced the platelet-inhibiting effects of aspirin, with 78% of patients showing incomplete inhibition of aggregation and higher thromboxane synthesis compared to controls. In vitro experiments confirmed that dipyrone diminishes aspirin's ability to inhibit platelet thromboxane synthesis.", "population_specificity": "Patients with stable cardiovascular, cerebrovascular, or peripheral arterial disease experiencing acute or chronic pain.", "effective_dosage": "Not specified (low-dose aspirin + dipyrone for at least 5 days).", "study_duration": "At least 5 days.", "interactions": "Dipyrone blunts platelet inhibition by low-dose aspirin.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:34.367271+00:00"}
{"study_id": 110411, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effects of a fortified milk powder containing arachidonic acid (among other nutrients) on micronutrient status and immune markers in pregnant women.", "results_summary": "Arachidonic acid levels were significantly higher in the intervention group during the second trimester (p=0.001), indicating effective absorption or utilization. No adverse effects or safety concerns related to arachidonic acid were reported.", "population_specificity": "Pregnant women in Jakarta, Indonesia.", "effective_dosage": "Not specified (part of a multi-nutrient fortified milk powder).", "study_duration": "From baseline to second trimester (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:34.865952+00:00"}
{"study_id": 110413, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between PUFAs (including Arachidonic Acid) and suicide, assessing whether PUFA depletion is a risk factor for suicidal behavior and exploring potential clinical applications.", "results_summary": "The study found mixed results regarding the role of PUFA depletion in suicidal behavior, with some evidence linking omega-3 deficiency to suicidal thoughts but large epidemiological studies not supporting this association. Increasing PUFA intake may help in depression treatment but lacks strong evidence for suicide prevention.", "population_specificity": "Subjects with psychiatric conditions, including bipolar disorder, unipolar depression, and suicidal behavior.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:34.994898+00:00"}
{"study_id": 110414, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of eicosanoid receptors derived from Arachidonic Acid in maintaining intestinal epithelium physiology and their implications in inflammatory bowel diseases and colorectal cancer.", "results_summary": "The study found that eicosanoid receptors play a key role in regulating intestinal epithelium functions, including proliferation, differentiation, and barrier integrity, and are implicated in inflammatory bowel diseases and colorectal cancer, suggesting therapeutic potential.", "population_specificity": "Intestinal epithelium (in vitro or animal models implied, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:35.785442+00:00"}
{"study_id": 110416, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify biological mechanisms, including arachidonic acid levels, linked to IFN-\u03b1-induced depression in HCV patients.", "results_summary": "The study found that the arachidonic acid / eicosapentaenoic acid plus docosahexaenoic acid ratio may present variations linked to a predisposition to IFN-\u03b1-induced depression, but replicated evidence is lacking.", "population_specificity": "HCV-infected patients receiving IFN-\u03b1-based immunotherapy (37.3% females, mean age 46.7 years).", "effective_dosage": "Not specified", "study_duration": "Follow-up ranged between 4 and 48 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:37.132431+00:00"}
{"study_id": 110415, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare platelet reactivity using arachidonic acid (ASPI) in healthy subjects and ischemic stroke patients, and to determine the prevalence of high on-treatment platelet reactivity (HPR) after aspirin loading doses.", "results_summary": "Arachidonic acid-induced platelet aggregation (ASPI) was significantly higher in AP-naive stroke patients compared to healthy controls (117 \u00b1 31 vs. 98 \u00b1 27, p < 0.005). Following aspirin loading doses, only 11.1% of patients met the criteria for aspirin resistance based on ASPI levels.", "population_specificity": "First-ever ischemic stroke patients (mean age 73 years) and age/sex-matched healthy controls.", "effective_dosage": "Not specified (standard treatment doses implied).", "study_duration": "Blood samples collected at baseline, 24 hours, and 3-5 days post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:37.497691+00:00"}
{"study_id": 110417, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether PCSO-524\u00ae, which decreases arachidonic acid concentrations, improves inattention, hyperactivity, mood, and cognition in children and adolescents.", "results_summary": "The study found no overall improvement in hyperactivity, inattention, or impulsivity with PCSO-524\u00ae compared to placebo, but post hoc analysis showed significant improvements in hyperactivity, attention, learning, and ADHD probability in a subsample without combined hyperactivity and inattention. Recognition memory improved at week 8 but not sustained by week 14.", "population_specificity": "144 children and adolescents (123 males, 21 females; mean age 8.7 years) with high hyperactivity and inattention.", "effective_dosage": "Not specified", "study_duration": "14 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:41.544263+00:00"}
{"study_id": 110418, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how omega-3 fatty acid treatment (OM3-CA) affects lipoprotein subspecies, including changes in arachidonic acid levels.", "results_summary": "OM3-CA increased arachidonic acid levels, which was associated with reductions in apoCIII, a marker linked to cardiovascular risk. The treatment selectively increased LDL without apoCIII, a subspecies weakly related to coronary heart disease.", "population_specificity": "399 subjects with fasting triglycerides of 500 to 2000 mg/dL.", "effective_dosage": "2, 3, or 4 g/d of OM3-CA.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:43.197322+00:00"}
{"study_id": 110420, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the optimal dosage of acetylsalicylic acid (ASA) for inhibiting platelet activation after coronary artery bypass grafting (CABG).", "results_summary": "The study found that ASA 75mg once daily was less effective at inhibiting platelet activation compared to ASA 160mg once daily or 75mg twice daily up to three months post-CABG. The 75mg twice daily dosage showed particular promise for further efficacy and clinical outcome studies.", "population_specificity": "42 patients undergoing elective CABG.", "effective_dosage": "75mg once daily, 160mg once daily, or 75mg twice daily.", "study_duration": "Three months post-operation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:43.883561+00:00"}
{"study_id": 110419, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of DHA supplementation on PUFA concentrations, including arachidonic acid (AA), in plasma and red blood cells over short and long-term periods.", "results_summary": "The study found that DHA supplementation significantly increased DHA and EPA levels while reducing AA concentrations, with a more pronounced decline in plasma (-24%) than in red blood cells (-16%).", "population_specificity": "12 healthy men with a mean age of 25.1\u00b11.5 years.", "effective_dosage": "1076mg/d of DHA (free of EPA).", "study_duration": "12 weeks (with measurements at 1, 3, 6, and 12 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:44.245896+00:00"}
{"study_id": 110421, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the accuracy of arachidonic acid (AA)-mediated assays in assessing aspirin's functional performance and explore the clinical implications of aspirin resistance.", "results_summary": "The study found that AA-induced platelet activation may not reliably assess aspirin's functional response, suggesting the existence of COX-1-independent pathways linked to vascular inflammation. The prevalence of aspirin resistance varies widely, affecting over 50% of some patient subgroups.", "population_specificity": "Patients with cardiovascular disease (specific subgroups not detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:44.566512+00:00"}
{"study_id": 110422, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the relationship between the AA:EPA ratio in red blood cells and infarct size/ventricular function in patients with STEMI.", "results_summary": "A higher AA:EPA ratio was associated with larger acute infarct size and worse long-term ventricular function, while higher EPA levels correlated with smaller infarct size and better ventricular function.", "population_specificity": "100 patients with reperfused anterior ST-elevation myocardial infarction (STEMI).", "effective_dosage": "Not specified", "study_duration": "Follow-up at one week and six months post-STEMI.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:44.615675+00:00"}
{"study_id": 110424, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were investigating the role of NLRP3 inflammasome activation in diabetic nephropathy (DN) and its association with hyperglycaemia, hyperlipidaemia, and hyperuricaemia.", "results_summary": "The study found that NLRP3 inflammasome activation, triggered by metabolic disturbances, plays a crucial role in the inflammatory cascade contributing to DN. However, the abstract does not mention Arachidonic Acid or its effects.", "population_specificity": "Patients with diabetic nephropathy (DN).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:45.736018+00:00"}
{"study_id": 110423, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether early initiation of EPA treatment (affecting the EPA/arachidonic acid ratio) in ACS patients reduces adverse cardiovascular events compared to statin monotherapy.", "results_summary": "The study found that early EPA treatment significantly reduced cardiovascular events (9.2% vs. 20.2% in controls) and cardiovascular death (0.8% vs. 4.2%) within 1 year, with a higher EPA/arachidonic acid ratio in the EPA group (1.15 vs. 0.40).", "population_specificity": "241 patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).", "effective_dosage": "1800 mg/day EPA + 2 mg/day pitavastatin.", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:46.231334+00:00"}
{"study_id": 110425, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the clinical roles of circulating PUFAs, including arachidonic acid (AA), in patients with acute decompensated heart failure (ADHF).", "results_summary": "Lower n-6 PUFA (AA + DGLA) levels on admission were significantly associated with worse clinical outcomes, including all-cause death and worsening HF, while n-3 PUFA levels showed no significant association. AA's role in adverse events was independently validated in multivariate analysis.", "population_specificity": "685 consecutive patients with acute decompensated heart failure (ADHF).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 560 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:49.564852+00:00"}
{"study_id": 110426, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the therapeutic potential of targeting P450-mediated arachidonic acid metabolism as a new drug strategy.", "results_summary": "The study highlights the promise of modulating P450-mediated arachidonic acid metabolism for therapeutic purposes, detailing efforts to develop new molecular entities and repurpose existing drugs. It emphasizes the need for systematic validation of clinically approved drugs for their new use in targeting AA metabolism.", "population_specificity": "Not specified (focus on general human P450 enzyme activity).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:50.848063+00:00"}
{"study_id": 110427, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the performance of the TEG6s system with the conventional TEG5000 in assessing hemostasis and response to antiplatelet therapy, particularly focusing on arachidonic acid as an indicator of aspirin response.", "results_summary": "The study found a strong correlation between the TEG6s and TEG5000 systems for standard hemostasis tests, with acceptable agreement in PlateletMapping assays for measuring arachidonic acid response. The results suggest the TEG6s system is reliable for assessing aspirin response via arachidonic acid.", "population_specificity": "Healthy volunteers (n = 157) and patients undergoing coronary revascularization (n = 300) at three hospitals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:52.732269+00:00"}
{"study_id": 110429, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the antiplatelet effects of extended-release acetylsalicylic acid (ER-ASA) in patients with type 2 diabetes mellitus.", "results_summary": "The study found that ER-ASA provided 24-hour antithrombotic effects with once-daily dosing, as assessed by multiple platelet function tests and thromboxane B measurements. However, specific efficacy outcomes or statistical significance were not detailed in the abstract.", "population_specificity": "Patients with type 2 diabetes mellitus (n=40) and multiple cardiovascular risk factors.", "effective_dosage": "162.5 mg/day", "study_duration": "14 \u00b1 4 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:53.072823+00:00"}
{"study_id": 110428, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers explored the therapeutic potential of bioactive compounds, including arachidonic acid, in rheumatoid arthritis treatment and the role of nano/submicromedicine in enhancing their delivery.", "results_summary": "Arachidonic acid was identified as a target for bioactive compounds due to its role in inflammatory mediators, but its direct efficacy was not isolated from other bioactives. Nano/submicromedicine improved the delivery and efficacy of these compounds, though specific outcomes for arachidonic acid alone were not detailed.", "population_specificity": "Not specified (general focus on rheumatoid arthritis therapy).", "effective_dosage": "Not specified (dose-dependent effects mentioned but no exact dosage for arachidonic acid).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:53.247753+00:00"}
{"study_id": 110431, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to explore the formation and signaling effects of nitrated derivatives of arachidonic acid (NO2-AA) in human plasma, cell membranes, and tissues.", "results_summary": "The study found that arachidonic acid can be nitrated by reactive nitrogen species, forming nitro-arachidonic acid (NO2-AA), which triggers signaling cascades via post-translational modifications of transcriptional regulatory proteins. It also highlighted AA's role as a precursor for prostaglandins and thromboxanes through enzymatic and non-enzymatic pathways.", "population_specificity": "Not specified (general human plasma, cell membranes, and tissues).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:54.114119+00:00"}
{"study_id": 110432, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of DHA supplementation on plasma fatty acid levels, including arachidonic acid (AA), and prostaglandin E metabolite (PGE-M) levels in pediatric CF patients.", "results_summary": "The study found no significant change in AA levels with DHA supplementation. Baseline AA levels were lower than previously reported for CF individuals, but supplementation did not alter these levels. Urine PGE-M levels decreased with both DHA and placebo, showing no significant difference between treatments.", "population_specificity": "Pediatric cystic fibrosis patients (ages 6-18) with pancreatic insufficiency.", "effective_dosage": "Not specified for AA (study focused on DHA at high and low doses).", "study_duration": "Three 4-week study periods with 4-week washout intervals.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:56.964187+00:00"}
{"study_id": 110434, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of genetic and epigenetic factors in arachidonic acid metabolism and their contribution to the severity and clinical phenotypes of aspirin-exacerbated respiratory disease (AERD).", "results_summary": "The study found that genetic variation in arachidonic acid metabolism pathways, along with epigenetic effects like DNA methylation, influences inflammatory states in AERD. It suggests that integrating genetic, epigenetic, and biomarker data could improve precision medicine for AERD and asthma treatment.", "population_specificity": "Individuals with aspirin-exacerbated respiratory disease (AERD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:59.266644+00:00"}
{"study_id": 110433, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to develop a cellular model of aspirin-exacerbated respiratory disease (AERD) to understand the role of arachidonic acid metabolism in NSAID intolerance.", "results_summary": "The study found that NSAIDs like indomethacin enhance cysteinyl leukotriene (cysLT) production in activated RBL-2H3 cells, suggesting a link between arachidonic acid metabolism and aspirin intolerance, but did not establish a direct effect of arachidonic acid itself.", "population_specificity": "Rat mast cell-like RBL-2H3 cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "NSAIDs (aspirin, indomethacin)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:59.289027+00:00"}
{"study_id": 110435, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review current and emerging drug targets, including arachidonic acid pathway inhibitors, for treating inflammatory diseases.", "results_summary": "The abstract highlights the limitations of current arachidonic acid pathway inhibitors and discusses the need for multi-target agents, mentioning AMP-activated protein kinase as a novel therapeutic target.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:52:59.658369+00:00"}
{"study_id": 110436, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to describe the biological processes involving arachidonic acid during orthodontic tooth movement and its role in tissue remodeling.", "results_summary": "The study found that orthodontic force triggers the synthesis and release of arachidonic acid, along with other biochemical mediators, contributing to tissue remodeling and adaptive responses in the periodontal ligament and alveolar bone.", "population_specificity": "Not specified (general orthodontic context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:00.571255+00:00"}
{"study_id": 110437, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of supplemented arachidonic acid (AA) and docosahexaenoic acid (DHA) on phospholipid metabolism in infants.", "results_summary": "The study found that infant plasma phospholipid profiles change significantly from newborn to 4 months and are influenced by dietary fatty acid composition. Supplementation with AA and DHA increased related phospholipid species, though AA levels remained lower than in breastfed infants.", "population_specificity": "Healthy term infants from the first month of life until 120 days old.", "effective_dosage": "Not specified (equal amounts of AA and DHA in intervention formula).", "study_duration": "From the first month of life until 120 days old.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:02.177965+00:00"}
{"study_id": 110438, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of 6-month EPA treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion, and endothelial dysfunction in patients with impaired glucose metabolism (IGM) and coronary artery disease (CAD).", "results_summary": "EPA treatment significantly improved postprandial triglyceride and glucose control, insulin secretion ability, and endothelial function, but did not affect hemoglobin A1c or fasting plasma glucose levels.", "population_specificity": "Newly diagnosed IGM patients with CAD (n=107).", "effective_dosage": "1800 mg/day of EPA.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:02.957537+00:00"}
{"study_id": 110430, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers were exploring the role of omega-3 polyunsaturated fatty acids (n-3 PUFAs) in depression, including potential treatment options, but did not specifically focus on Arachidonic Acid.", "results_summary": "The abstract discusses conflicting conclusions regarding the efficacy of n-3 PUFAs in reducing depression symptoms, with some evidence suggesting their potential role in mood disorders, but no specific findings on Arachidonic Acid are mentioned.", "population_specificity": "General population, including adults and children, with a focus on depression.", "effective_dosage": "Not specified for Arachidonic Acid.", "study_duration": "Not specified for Arachidonic Acid.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:05.778003+00:00"}
{"study_id": 110441, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether preoperative platelet function, including arachidonic acid-induced aggregation, could predict severe bleeding complications in ticagrelor-treated cardiac surgery patients.", "results_summary": "Arachidonic acid-induced platelet aggregation showed low accuracy in predicting severe bleeding (area under ROC curve 0.53), indicating minimal predictive efficacy compared to ADP-induced aggregation.", "population_specificity": "Ninety ticagrelor-treated cardiac surgery patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:07.097650+00:00"}
{"study_id": 110439, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the pharmacodynamic effects of prasugrel and ticagrelor on ADP- and non-ADP-induced (including arachidonic acid) platelet signaling pathways in diabetic patients with coronary artery disease.", "results_summary": "The study found that both prasugrel and ticagrelor significantly reduced ADP- and non-ADP-induced platelet reactivity, with no significant difference in the inhibition of non-ADP pathways (including arachidonic acid) between the two drugs.", "population_specificity": "Aspirin-treated diabetic patients (n=50) with coronary artery disease.", "effective_dosage": "Not specified for arachidonic acid (used as an inducer in assays, not as a supplement).", "study_duration": "1 week.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:07.809295+00:00"}
{"study_id": 110442, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the role of arachidonic acid biosynthesis abnormalities in Aspirin-exacerbated respiratory disease (AERD) and explore treatment modalities.", "results_summary": "The study found that AERD is linked to abnormalities in arachidonic acid biosynthesis and involves eosinophilic activation in nasal polyp tissues. Treatment options include aspirin desensitization, leukotriene-modifying agents, and biologics, but the abstract does not detail specific outcomes related to arachidonic acid supplementation.", "population_specificity": "Patients with Aspirin-exacerbated respiratory disease (AERD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:07.990002+00:00"}
{"study_id": 110440, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether changes in blood levels of arachidonic acid (AA) were associated with PTSD symptom severity in trauma-injured patients receiving omega-3 supplements.", "results_summary": "The study found that increased AA levels were positively correlated with PTSD severity, suggesting a potential negative association. No protective effect of AA was observed, unlike EPA, which showed an inverse correlation with PTSD symptoms.", "population_specificity": "110 participants with severe physical injury in Japan.", "effective_dosage": "Not specified for AA (intervention was 1,470mg DHA and 147mg EPA daily).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:08.051304+00:00"}
{"study_id": 110443, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Arachidonic Acid and other n-6 fatty acids were associated with CD4 cell counts and clinical outcomes (death or hospitalization) in HIV-infected patients on antiretroviral therapy.", "results_summary": "The study found no significant association between Arachidonic Acid levels and CD4 counts during follow-up or the risk of death/hospitalization, unlike linoleic acid and gamma-linolenic acid, which showed protective effects.", "population_specificity": "HIV-infected patients in Uganda on antiretroviral therapy.", "effective_dosage": "Not specified", "study_duration": "18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:08.835989+00:00"}
{"study_id": 110444, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) in very low birth weight infants affects growth, metabolic markers, and cognitive function at 8-year follow-up.", "results_summary": "The study found that AA and DHA supplementation led to significantly lower insulin-like growth factor-1 (IGF-1) levels at 8 years but did not affect growth or IQ. Current DHA status, but not AA, was positively associated with higher IQ at follow-up.", "population_specificity": "Very low birth weight infants (birth weight <1500 g) fed human milk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:10.592150+00:00"}
{"study_id": 110445, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to clarify the relationship between the omega-6 to omega-3 fatty acid ratio and depression, including the role of Arachidonic Acid in eicosanoid production and membrane fluidity.", "results_summary": "The study found that an increased omega-6 to omega-3 ratio may contribute to depression through mechanisms like pro-inflammatory cytokine production and altered membrane fluidity, while omega-3 supplementation showed positive effects in clinical trials.", "population_specificity": "Depressive patients (specific demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:10.728620+00:00"}
{"study_id": 110446, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether ivacaftor treatment affects plasma fatty acid levels, particularly arachidonic acid, and urine prostaglandin E metabolite levels in individuals with cystic fibrosis.", "results_summary": "Arachidonic acid levels decreased with ivacaftor treatment, and there was a significant reduction in its metabolite PGE-M in urine. However, other fatty acid abnormalities typical in CF, such as low linoleic acid and docosahexaenoic acid levels, were not corrected.", "population_specificity": "40 subjects with cystic fibrosis (G551D mutation responders) from the GOAL study.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:14.058798+00:00"}
{"study_id": 110451, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize the relationship between non-cardiac biomarkers, including the ratio of eicosapentaenoic acid to arachidonic acid, and periprocedural myocardial injury (PMI) following percutaneous coronary intervention (PCI).", "results_summary": "The study found that the ratio of eicosapentaenoic acid to arachidonic acid was positively correlated with PCI-related PMI, suggesting a potential association, but no definitive mechanism was provided.", "population_specificity": "Patients with coronary artery disease undergoing PCI.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:15.777918+00:00"}
{"study_id": 110448, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of arachidonic acid-derived lipids as mediators in diseases, particularly viral infections, and their classification into pro-inflammatory and anti-inflammatory molecules.", "results_summary": "The study found that arachidonic acid-derived lipids are classified into three classes, with Class 1 and 2 acting as pro-inflammatory molecules (upregulated in diseases like cancer and viral infections) and Class 3 as anti-inflammatory molecules (potentially useful for treating inflammation-related diseases). The unique functions of each class contribute to cellular homeostasis.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.087358+00:00"}
{"study_id": 110447, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize current knowledge about the pathophysiology of AERD, focusing on diagnostic approaches and discussing aspirin desensitization protocols.", "results_summary": "The study highlights that AERD is linked to altered arachidonic acid metabolism and dysregulated enzyme activity, leading to severe symptoms like asthma attacks and nasal polyps. Aspirin desensitization is noted as the only causative treatment, but optimal protocols remain debated.", "population_specificity": "Individuals with aspirin-exacerbated respiratory disease (AERD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "NSAIDs (adverse reactions noted)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.193537+00:00"}
{"study_id": 110450, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate methods for normalizing platelet function data, including responses to arachidonic acid, to improve statistical and clinical interpretation.", "results_summary": "The study compared normalization techniques for platelet function data, finding that interquartile range, range transformation, and z-transformation showed correlation when normalized per assay, but no correlation was observed when normalized per time point. Arachidonic acid was used as one of the agonists in platelet function assays, but specific effects were not detailed.", "population_specificity": "Not specified (study focused on methodological analysis of platelet function data).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.265409+00:00"}
{"study_id": 110452, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of TRPV4 ion channels, including their modulation by arachidonic acid metabolites, in various physiological and pathophysiological processes.", "results_summary": "The abstract highlights that TRPV4 is modulated by arachidonic acid metabolites and plays a role in pain sensation, vascular regulation, and epithelial/endothelial barrier function, with implications in diseases like hypertension, diabetes, and respiratory disorders.", "population_specificity": "Not specified (primarily discusses mechanisms and animal models like TRPV4 knockout mice).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.571816+00:00"}
{"study_id": 110454, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review recent advances in compounds influencing the LOX pathway, derived from arachidonic acid, and their potential clinical applications in treating asthma, cancer, and cardiovascular diseases.", "results_summary": "The study highlights the role of arachidonic acid-derived leukotrienes in inflammatory diseases and discusses new compounds targeting the LOX pathway currently under clinical investigation for asthma, cancer, and cardiovascular conditions.", "population_specificity": "Not specified (general review of clinical studies)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:18.451314+00:00"}
{"study_id": 110453, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the association between the DHA/AA ratio and acute coronary syndrome (ACS) across different patient subgroups.", "results_summary": "A high DHA/AA ratio was significantly associated with a lower risk of ACS in men, while a reverse (non-significant) trend was observed in women. The association varied by clinical characteristics, particularly sex and hypertension status.", "population_specificity": "1733 patients from 5 cardiology departments in a metropolitan area of Japan, stratified by sex, age, diabetes, hypertension, dyslipidemia, smoking history, family history of ischemic heart disease, chronic kidney disease, obesity, and history of coronary revascularization.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.849824+00:00"}
{"study_id": 110455, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the interaction between epoxygenase-dependent metabolites of arachidonic acid (EETs) and the heme-oxygenase (HO)-1 system, and their combined therapeutic potential in various physiological functions.", "results_summary": "The study found that EETs and the HO-1 system share similar beneficial effects, including improving endothelial function, reducing blood pressure, protecting against heart and liver damage, promoting angiogenesis, and combating oxidative stress and inflammation. EETs also induce HO-1, and inhibiting HO-1 negates most of EETs' effects, indicating a close interaction between the two systems.", "population_specificity": "Not specified (likely preclinical or in vitro models based on abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:23.392452+00:00"}
{"study_id": 110456, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the cardiovascular effects of COX-2 inhibitors, focusing on mechanisms contributing to clinical outcomes of COX-2 inhibition in arachidonic acid metabolism.", "results_summary": "The study highlights that COX-2, a key enzyme in arachidonic acid metabolism, is involved in diverse physiological and pathophysiological processes, including inflammation, blood pressure regulation, and colorectal tumorigenesis. COX-2 inhibitors exhibit varied clinical effects, from reducing pain and inflammation to increasing cardiovascular risks and decreasing cancer risk.", "population_specificity": "Not specified (general discussion of human tissues and cell types).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.097397+00:00"}
{"study_id": 110459, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential synergistic effects of \u03c9-3 and \u03c9-6 LCPUFA combinations, including Arachidonic Acid, in resolving inflammation and controlling symptoms in bronchial asthma.", "results_summary": "The study suggests that dietary supplementation with LCPUFA, including Arachidonic Acid, may help rebuild fatty acid homeostasis, modify eicosanoid pathways, and resolve inflammation in the bronchoalveolar system, potentially aiding in asthma symptom control.", "population_specificity": "Individuals with allergic bronchial asthma, particularly those with early-phase or milder forms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.159890+00:00"}
{"study_id": 110458, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the impact of dipyrone comedication on aspirin's antiplatelet effects and neurological outcomes in stroke patients, using arachidonic acid-induced aggregation as a measure.", "results_summary": "The study found that dipyrone comedication impaired aspirin's antiplatelet effects in 62% of stroke patients, leading to worse neurological recovery compared to aspirin alone. Arachidonic acid-induced aggregation was significantly higher in the aspirin+dipyrone group, indicating reduced efficacy of aspirin.", "population_specificity": "41 patients with stroke", "effective_dosage": "Not specified", "study_duration": "Three months follow-up", "interactions": "Dipyrone impaired aspirin's antiplatelet effects", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.470456+00:00"}
{"study_id": 110457, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of vorapaxar and aspirin on bleeding time and platelet aggregation using arachidonic acid as an agonist.", "results_summary": "The study found that vorapaxar did not prolong bleeding time compared to baseline, unlike aspirin. When combined with aspirin, bleeding time was similar to aspirin alone, suggesting no additional effect from vorapaxar.", "population_specificity": "Healthy men (n = 31) and women (n = 5).", "effective_dosage": "Arachidonic acid was used as an agonist for platelet aggregation testing; specific dosage not provided.", "study_duration": "7 days for each treatment period (total 14 days).", "interactions": "Vorapaxar and aspirin were studied in combination, showing additive effects on bleeding time.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:25.329400+00:00"}
{"study_id": 110460, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the role of 20-HETE, a metabolite of arachidonic acid, in vascular regulation, hypertension, and pathological conditions like inflammation and oxidative stress.", "results_summary": "The study found that 20-HETE, derived from arachidonic acid, acts as a potent vasoconstrictor and contributes to vascular dysfunction, inflammation, and oxidative stress in conditions like obesity and diabetes. It also highlighted interactions with the renin-angiotensin system and potential clinical implications of inhibiting 20-HETE.", "population_specificity": "Mammals (general, no specific human or animal subgroup mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Renin-angiotensin system mentioned as an interaction.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:25.483795+00:00"}
{"study_id": 110461, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 PUFAs (docosahexaenoic acid and eicosapentaenoic acid) could effectively prevent psychophysiological symptoms of PTSD in accident survivors.", "results_summary": "The study found that omega-3 supplementation significantly reduced heart rate during rest and script-driven imagery compared to placebo, suggesting potential benefits for PTSD symptom prevention. Baseline heart rates were similar between groups.", "population_specificity": "Japanese accident survivors with mostly non-severe PTSD symptoms.", "effective_dosage": "1470mg docosahexaenoic acid and 147mg eicosapentaenoic acid per day.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:27.087734+00:00"}
{"study_id": 110462, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the association between FADS genotypes and LC PUFA levels, including arachidonic acid (AA), in erythrocyte membranes of MCI patients, and their potential links to cognitive decline and depressive symptoms.", "results_summary": "Minor allele carriers of certain FADS SNPs showed significantly lower AA levels in erythrocyte membranes compared to major allele carriers, though differences in EPA and DHA levels were not significant. A low omega-3 index, which includes AA, was associated with depressive symptoms in MCI patients.", "population_specificity": "111 patients with mild cognitive impairment (MCI)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:28.542741+00:00"}
{"study_id": 110463, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the association between arachidonic acid (ARA) levels, lipid mediators, and allergy symptoms in iron-deficient South African children.", "results_summary": "The study found that allergic children had lower PBMC ARA levels and ARA/DGLA ratios but higher plasma inflammatory and resolving lipid mediators, suggesting altered fatty acid metabolism and inflammation linked to allergy symptoms.", "population_specificity": "Rural, iron-deficient South African children aged 6-11 years with parent-reported allergy data (n=111, allergic=30, non-allergic=81).", "effective_dosage": "Not specified", "study_duration": "Not specified (baseline data from an intervention study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:32.360140+00:00"}
{"study_id": 110466, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess whether arachidonic acid (AA) levels differed between adults with ADHD and controls as part of a broader investigation into biochemical markers for adult ADHD.", "results_summary": "The study found no significant differences in arachidonic acid (AA) levels between adults with ADHD and controls, unlike docosahexaenoic acid (DHA), which showed lower levels in ADHD patients.", "population_specificity": "Adults with attention-deficit/hyperactivity disorder (ADHD) and controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:32.367898+00:00"}
{"study_id": 110465, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate high platelet reactivity under aspirin treatment in comatose patients resuscitated from out-of-hospital cardiac arrest, using arachidonic acid as an aggregometry agent.", "results_summary": "The study found that intravenous aspirin resulted in significantly lower platelet aggregation compared to oral administration when assessed using arachidonic acid. However, high platelet reactivity under aspirin treatment was still frequent in both groups.", "population_specificity": "Comatose patients resuscitated from out-of-hospital cardiac arrest of cardiac origin.", "effective_dosage": "Aspirin 100mg per day (intravenously or orally via gastric tube).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:32.708570+00:00"}
{"study_id": 110464, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to assess differences in dietary and serum fatty acid levels, including arachidonic acid (AA), between ulcerative colitis (UC) subjects and controls, and their associations with disease activity and inflammatory cytokines.", "results_summary": "UC subjects had decreased AA intake compared to controls, and lower serum AA levels. Tissue cytokine levels were inversely correlated with PUFA, EPA, and DPA in UC subjects, but AA's direct effects were not explicitly highlighted.", "population_specificity": "137 UC subjects and 38 controls.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "5-aminosalicylic acid therapy blunted associations between fatty acids and cytokines.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:32.956865+00:00"}
{"study_id": 110467, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of arachidonic acid metabolites (EETs) and sEH inhibitors in managing diabetes and obesity-related cardiovascular diseases.", "results_summary": "The study highlights that EETs, derived from arachidonic acid, have beneficial effects in diabetes and cardiovascular diseases, and sEH blockers show promise in enhancing these effects by preventing EET degradation.", "population_specificity": "Individuals with type 1 diabetes, type 2 diabetes, and obesity-related cardiovascular diseases.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:32.958292+00:00"}
{"study_id": 110468, "supplement_id": 885, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether n-3 PUFA (including Arachidonic Acid) could enhance the effectiveness of conventional and targeted anticancer therapies by increasing cancer sensitivity to treatment.", "results_summary": "The study suggests that n-3 PUFA may improve the antineoplastic efficiency of existing therapies, potentially allowing lower drug/radiation doses and reducing side effects. However, it is unlikely to be effective as a standalone cancer treatment.", "population_specificity": "Not specified (general discussion of n-3 PUFA in cancer therapy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:34.032234+00:00"}
{"study_id": 110469, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolites in chronic inflammatory diseases and their potential as therapeutic targets.", "results_summary": "The study highlights arachidonic acid metabolites as key mediators in chronic inflammation, oxidative stress, and thromboatherosclerosis, suggesting their involvement in disease pathogenesis and potential for therapeutic intervention.", "population_specificity": "Not specified (general discussion of chronic inflammatory diseases).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:34.225314+00:00"}
{"study_id": 110470, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the association between serum free fatty acids, including arachidonic acid, and cardiometabolic/inflammatory biomarkers in obese adolescents undergoing interdisciplinary therapy.", "results_summary": "The study found that interdisciplinary therapy increased arachidonic acid levels in obese adolescents, alongside improvements in metabolic, inflammatory, and cardiometabolic profiles. Arachidonic acid changes were part of broader fatty acid profile shifts linked to biomarker modulation.", "population_specificity": "108 postpuberty obese adolescents (32 with metabolic syndrome, 76 without).", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:37.322693+00:00"}
{"study_id": 110473, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review evidence on the essentiality of arachidonic acid (AA) and docosahexaenoic acid (DHA) in infant and maternal diets for immune system development.", "results_summary": "The study found that AA and DHA supplementation in infant formula improved immune function markers and reduced the risk of allergic and atopic diseases, though more research is needed to confirm AA's essentiality. Results were more consistent for preterm infants than full-term infants.", "population_specificity": "Infants (preterm and full-term) and breastfeeding mothers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:40.857213+00:00"}
{"study_id": 110471, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers sought to evaluate the effects of omega-3 supplementation on inflammatory parameters and erythrocyte fatty acid profiles, including changes in arachidonic acid (AA) levels, in cystic fibrosis patients.", "results_summary": "Omega-3 supplementation significantly increased EPA and DHA levels while decreasing AA levels within 3 months. The study suggests that long-term omega-3 supplementation may reduce pulmonary exacerbations and antibiotic therapy duration in CF patients.", "population_specificity": "Fifteen \u0394F508-homozygous cystic fibrosis patients undergoing chronic azithromycin treatment.", "effective_dosage": "60 mg/kg/day of omega-3 fish oil.", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:41.386722+00:00"}
{"study_id": 110474, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of arachidonic acid in atherosclerosis, particularly its involvement in signaling mechanisms related to AT<sub>2</sub>R and phospholipase A(2) activation.", "results_summary": "The study highlighted arachidonic acid's role in atherosclerosis through its release via phospholipase A(2) activation, suggesting it as a potential target for future drug development. No direct effects or clinical outcomes of arachidonic acid were reported.", "population_specificity": "Not specified (general focus on atherosclerosis mechanisms)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:41.619917+00:00"}
{"study_id": 110472, "supplement_id": 885, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the effectiveness and safety of Chinese herbal medicine (CHM) as an alternative or adjunctive therapy for aspirin resistance (AR), with a focus on its impact on platelet aggregation induced by arachidonic acid (AA).", "results_summary": "The study found that CHM plus aspirin significantly reduced platelet aggregation rate (PAR) induced by AA compared to aspirin alone, and also showed reductions in thromboxane B2 (TXB2) levels. Additionally, CHM plus aspirin was associated with fewer adverse events and no increased bleeding risk.", "population_specificity": "1,460 patients with aspirin resistance (AR).", "effective_dosage": "Not specified for AA; aspirin dosage was 100mg/d.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.070359+00:00"}
{"study_id": 110475, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To investigate the effect of piroxicam (a cyclooxygenase inhibitor affecting arachidonic acid metabolism) on the success rate of intrauterine insemination (IUI) in women with unexplained infertility.", "results_summary": "Piroxicam administration after IUI was associated with a higher pregnancy rate (19.2% vs. 12.3%) and pregnancy rate per cycle (11.16 vs. 6.66) compared to placebo, but did not affect abortion, multiple pregnancy, or ongoing pregnancy rates.", "population_specificity": "260 women with unexplained infertility undergoing IUI cycles.", "effective_dosage": "10 mg/day on days 4-6 after IUI.", "study_duration": "3 days per cycle.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.421175+00:00"}
{"study_id": 110477, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether high on-treatment platelet reactivity (HTPR) measured by arachidonic acid-induced aggregation assays was associated with cardiovascular event recurrence in stable cardiovascular outpatients on aspirin monotherapy.", "results_summary": "The study found no significant association between HTPR (measured via arachidonic acid- or collagen-induced assays) or residual COX-1 activity and cardiovascular event recurrence, suggesting these tests may not predict clinical outcomes in this population.", "population_specificity": "592 stable cardiovascular outpatients on aspirin monotherapy for secondary prevention.", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.629456+00:00"}
{"study_id": 110476, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to outline recent achievements in identifying highly selective COX-1 inhibitors derived from synthetic and plant sources, focusing on their theranostic use in neuroinflammation and ovarian cancer.", "results_summary": "The study highlights the role of COX-1 in cancer progression, particularly in epithelial ovarian cancer, and discusses the design of new selective COX-1 inhibitors. It also notes the gastrotoxic effects of these inhibitors.", "population_specificity": "Human epithelial ovarian cancer and neuroinflammation contexts (not specified if human or animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.762309+00:00"}
{"study_id": 110478, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine whether rosuvastatin affects thromboxane-mediated platelet aggregation using arachidonic acid as an agonist in patients with a history of venous thrombosis.", "results_summary": "The study found no significant effect of rosuvastatin on platelet reactivity when arachidonic acid was used as an agonist, with similar PRU measurements before and after treatment in both rosuvastatin users and non-users. Results remained consistent even after excluding patients on antiplatelet medication or with thrombocytopenia.", "population_specificity": "Patients with a history of venous thrombosis (50 participants, 25 receiving rosuvastatin and 25 without intervention).", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:47.696174+00:00"}
{"study_id": 110481, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of prostaglandins derived from arachidonic acid in biological processes and their therapeutic potential, particularly in treating glaucoma.", "results_summary": "The abstract highlights that prostaglandin analogues derived from arachidonic acid effectively lower intraocular pressure (IOP), a key factor in glaucoma treatment, and explores ongoing research targeting various prostaglandin receptors.", "population_specificity": "Not specified (general review of prostaglandin research).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:49.283697+00:00"}
{"study_id": 110479, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the anti-acne effects of non-psychotropic phytocannabinoids, including their interaction with arachidonic acid (AA)-induced lipogenesis.", "results_summary": "The study found that CBC, CBDV, and THCV significantly reduced AA-induced 'acne-like' lipogenesis in human sebocytes, while CBG and CBGV increased basal lipid synthesis. THCV also suppressed proliferation, and all tested phytocannabinoids exhibited notable anti-inflammatory effects.", "population_specificity": "Human SZ95 sebocytes (a model for sebaceous gland function).", "effective_dosage": "Up to 10 \u03bcM for viability tests; \u226550 \u03bcM for apoptosis induction.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.752699+00:00"}
{"study_id": 110480, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to understand how metabolic and genetic factors influence the conversion of GLA to DGLA and AA, and how these factors affect the clinical effectiveness of GLA or GLA/(n-3) PUFA supplements in treating inflammatory conditions.", "results_summary": "The study found that the conversion of GLA to DGLA and AA, and their subsequent metabolism, varies among individuals due to cellular, tissue, and genetic factors, leading to inconsistent clinical outcomes in treating inflammatory conditions. The opposing effects of DGLA and AA metabolites on inflammation further complicate the efficacy of PUFA-based supplements.", "population_specificity": "Not specified (general human population implied, with focus on metabolic and genetic variability).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.877609+00:00"}
{"study_id": 110484, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether ALOX5 gene variants and plasma concentrations of arachidonic acid influence carotid intima-media thickness (cIMT) and incident coronary heart disease (CHD).", "results_summary": "The study found no significant associations between ALOX5 gene variants and cIMT or CHD events, nor did plasma levels of arachidonic acid modify these relationships.", "population_specificity": "6153 multi-ethnic participants from the Multi-Ethnic Study of Atherosclerosis (MESA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:51.112814+00:00"}
{"study_id": 110482, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify risk factors for nonplatelet thromboxane A2 generation, particularly focusing on the role of oxidative stress-induced arachidonic acid metabolite 8-iso-PGF2\u03b1.", "results_summary": "The study found that oxidative stress-induced formation of 8-iso-PGF2\u03b1, an arachidonic acid metabolite, was strongly associated with nonplatelet thromboxane formation and early vein graft thrombosis after coronary artery bypass graft surgery. Endothelial cells were identified as a potential source of oxidative stress-induced thromboxane generation.", "population_specificity": "260 subjects who underwent coronary artery bypass graft surgery with verified aspirin-mediated inhibition of platelet thromboxane A2 generation.", "effective_dosage": "Not specified", "study_duration": "6 months post-surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:51.655114+00:00"}
{"study_id": 110483, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether reducing the n-6:n-3 LCPUFA ratio in maternal diets during pregnancy and lactation affects offspring body composition by preschool age.", "results_summary": "The study found no significant differences in body composition, growth, or fat distribution in children whose mothers had a reduced n-6:n-3 LCPUFA ratio compared to controls, indicating no preventive effect against obesity.", "population_specificity": "Pregnant and lactating women and their offspring (followed from birth to 5 years).", "effective_dosage": "1020 mg DHA + 180 mg EPA daily, with an arachidonic acid-balanced diet.", "study_duration": "Intervention during pregnancy and lactation, with follow-up until children were 5 years old.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:52.547833+00:00"}
{"study_id": 110485, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the necessity of arachidonic acid (ARA) as a nutrient in term infants, particularly in conjunction with docosahexaenoic acid (DHA), and to challenge the European Food Safety Authority's assertion that ARA is optional.", "results_summary": "The study highlights that ARA is a major structural component of the central nervous system and is required for signaling. It found that infants derive about half of their total body ARA from dietary sources, and one study with higher ARA levels showed significant neurocognitive benefits, though no ARA-specific outcomes like vascular or immune function were considered.", "population_specificity": "Term infants, particularly those breastfed by adequately nourished mothers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:52.667703+00:00"}
{"study_id": 110486, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers investigated whether the G allele of rs13431554 in the IRS-1 gene is associated with increased platelet reactivity in response to arachidonic acid in CAD patients with T2DM.", "results_summary": "The study found that G allele carriers of rs13431554 had significantly higher arachidonic acid-induced platelet aggregation compared to non-carriers, indicating a hyperreactive platelet phenotype. P-selectin expression and PAC-1 binding were also higher in G allele carriers.", "population_specificity": "674 coronary artery disease (CAD) patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:57.157246+00:00"}
{"study_id": 110487, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid metabolizing enzymes (COX-2 and 5-LOX) in colorectal cancer development and the potential of dual COX/5-LOX inhibitors as a therapeutic option.", "results_summary": "The study found that COX-2 and 5-LOX are highly expressed during colorectal carcinogenesis, with cigarette smoke promoting these processes early in adenoma formation. Dual inhibition of 5-LOX/COX was suggested as a promising therapeutic approach for colorectal cancer.", "population_specificity": "Colorectal cancer patients or models (specific human or animal population not detailed in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:58.668430+00:00"}
{"study_id": 110489, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of arachidonic acid metabolites, particularly prostacyclin (PGI2), in atherothrombotic risk and cardiovascular protection.", "results_summary": "The study found that PGI2, a metabolite of arachidonic acid, may have a protective effect against atherothrombotic risk, with reduced levels linked to increased cardiovascular events. COX-2 selective NSAIDs, which lower PGI2, were associated with a 2- to 3-fold higher risk of thrombotic events like myocardial infarction or stroke.", "population_specificity": "Patients at high cardiovascular risk, particularly those with diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "COX-2 selective NSAIDs (negative interaction by reducing PGI2 levels)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:00.477170+00:00"}
{"study_id": 110491, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the genetic association between copy number variations in arachidonic acid pathway genes and NSAIDs-induced urticaria/angioedema (NIUA).", "results_summary": "The study found statistically significant associations between CNVs in ALOX5 and PTGER1 genes and NIUA, suggesting a potential role of these genetic variations in the pathology of NIUA.", "population_specificity": "151 cases and 139 controls in the discovery phase; 148 cases and 140 controls in the replication phase.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:00.555593+00:00"}
{"study_id": 110493, "supplement_id": 885, "safety_score": "60", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers examined whether arachidonic acid, as a putative pro-algesic dietary component, could induce or worsen pain and if reducing its intake might improve chronic pain.", "results_summary": "The study found that overconsumption of arachidonic acid may induce or worsen pain, but reducing its intake does not consistently reduce pain. The mechanism by which it may act to induce pain was discussed, though clinical trial evidence was limited.", "population_specificity": "Not specified (general discussion of chronic pain patients implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:01.052649+00:00"}
{"study_id": 110488, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess changes in arachidonic acid and other PUFA levels in children with severe acute malnutrition during therapeutic feeding and identify predictors of these changes.", "results_summary": "Arachidonic acid levels decreased significantly during treatment, with a reduction of 0.79 FA% from admission to transition and 0.10 FA% at discharge. The study found that current therapeutic feeds do not correct low levels of long-chain PUFAs, including arachidonic acid, in malnourished children.", "population_specificity": "120 children with severe acute malnutrition (38% female, 64% with edema) and 29 healthy controls in Kampala, Uganda.", "effective_dosage": "Not specified", "study_duration": "Follow-up at 8 and 16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:01.487692+00:00"}
{"study_id": 110492, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "To determine if postnatal supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) improves cerebral white matter microstructure and behavioral outcomes in very low birth weight infants at 8 years of age.", "results_summary": "No significant differences were found between the intervention and control groups in white matter microstructure or behavioral outcomes. A non-significant increase in fractional anisotropy in the corpus callosum was noted in the intervention group.", "population_specificity": "Very low birth weight infants (birth weight <1500 g) fed human milk.", "effective_dosage": "Not specified", "study_duration": "Postnatal supplementation (exact duration not specified) with follow-up at 8 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:01.727780+00:00"}
{"study_id": 110490, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess whether NOACs (dabigatran or rivaroxaban) affect the antiplatelet effects of ASA (via arachidonic acid-induced aggregation) or clopidogrel in patients with atrial fibrillation and coronary artery disease.", "results_summary": "The study found no significant differences in arachidonic acid-induced platelet aggregation in patients taking NOACs (dabigatran or rivaroxaban) with or without concomitant ASA, indicating NOACs do not interfere with ASA's antiplatelet effects.", "population_specificity": "Patients with non-valvular atrial fibrillation and coronary artery disease, some taking concomitant platelet inhibitors (ASA or clopidogrel).", "effective_dosage": "Arachidonic acid (0.5 mM) used to induce platelet aggregation.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned regarding arachidonic acid specifically.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:02.075482+00:00"}
{"study_id": 110494, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether the MBOAT7-TMC4 locus, associated with arachidonic acid metabolism, is a susceptibility factor for the development and progression of NAFLD.", "results_summary": "The study found that the rs641738 variant at the MBOAT7-TMC4 locus was associated with increased hepatic fat content, more severe liver damage, and higher fibrosis risk, mediated by changes in hepatic phosphatidylinositol acyl-chain remodeling.", "population_specificity": "Multi-ethnic participants from the Dallas Heart Study (3854) and European individuals from the Liver Biopsy Cross-Sectional Cohort (1149).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:06.677940+00:00"}
{"study_id": 110496, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolites in modulating vascular tone and their implications in microvascular dysfunction and cardiovascular events.", "results_summary": "The abstract highlights that arachidonic acid metabolites, along with other compounds, play a critical role in vascular tone modulation and may contribute to microvascular dysfunction under stress or disease, leading to inflammation, thrombosis, and fibrosis.", "population_specificity": "Human microcirculation (general, not specific demographic).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:09.243511+00:00"}
{"study_id": 110497, "supplement_id": 885, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential anti-inflammatory and therapeutic effects of n-3 PUFAs, including EPA and DHA, on asthma symptoms and severity.", "results_summary": "The study suggests that n-3 PUFAs, particularly EPA and DHA, may reduce inflammation and asthma severity by altering cell membrane composition and producing less inflammatory lipid mediators, such as E-series resolvins. No major health side effects were reported with n-3 fatty acid supplementation.", "population_specificity": "Individuals with asthma (over 300 million worldwide).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:09.521529+00:00"}
{"study_id": 110498, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate how circulating fatty acid ethanolamide (FAE) levels, including those derived from arachidonic acid, are influenced by dietary fatty acid intake in humans.", "results_summary": "The study found that plasma FAE levels were modulated by dietary fatty acids and correlated with corresponding plasma fatty acid levels, with genetic variations influencing FAE levels. Elevated DHEA levels from DHA intake were associated with lower OEA levels and increased gynoid fat mass.", "population_specificity": "Volunteers with abdominal obesity", "effective_dosage": "60 g per day (3000 kcal per day)", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:09.854626+00:00"}
{"study_id": 110500, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of arachidonic acid compounds in inflammatory processes, particularly their involvement in vascular permeability, pain sensitization, and neurological disorders.", "results_summary": "The abstract highlights that arachidonic acid compounds contribute to inflammatory responses, including vascular permeability and pain receptor sensitization, and are implicated in neurological disorders through mechanisms involving TNF and NF-\u03baB activation. However, specific effects or outcomes related to arachidonic acid supplementation or intervention are not detailed.", "population_specificity": "Not specified (general discussion of inflammatory and neurological mechanisms)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:11.095747+00:00"}
{"study_id": 110499, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the historical context and scientific evidence supporting the inclusion of arachidonic acid in infant formulas, focusing on its essentiality and the challenges in understanding its role.", "results_summary": "The study highlights that arachidonic acid, along with other PUFAs, was recognized as essential for infant nutrition, though understanding its role in neural function was delayed due to methodological challenges. Preclinical animal studies significantly influenced human clinical studies, but the abstract suggests re-evaluation of the essential fatty acid concept based on current evidence.", "population_specificity": "Premature infants and general infant nutrition (indirectly addressed through historical and preclinical evidence).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:12.483202+00:00"}
{"study_id": 110501, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid-derived prostacyclin (PGI2) in pulmonary arterial hypertension (PAH) and the efficacy of PGI2 analogues as therapeutic agents.", "results_summary": "The study found that PGI2 analogues, derived from arachidonic acid, improve survival, functional class, and exercise capacity in PAH patients, though their delivery systems have significant limitations and adverse effects.", "population_specificity": "Patients with pulmonary arterial hypertension (PAH), particularly those with severe or advanced disease.", "effective_dosage": "Not specified for arachidonic acid; varies for PGI2 analogues (e.g., continuous intravenous infusion for epoprostenol, six to nine times daily for iloprost).", "study_duration": "Not specified for arachidonic acid; varies for PGI2 analogues.", "interactions": "None mentioned for arachidonic acid; PGI2 analogues have noted adverse effects (e.g., central line infections, thrombosis, injection site pain).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:13.933361+00:00"}
{"study_id": 110495, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the potential use of omega-3 fatty acids, including arachidonic acid, in the treatment of epilepsy and explore their proposed mechanisms of action.", "results_summary": "The abstract suggests that omega-3 fatty acids, including arachidonic acid, may have neuroprotective and anticonvulsant effects, potentially offering benefits in epilepsy treatment, but does not provide specific results for arachidonic acid alone.", "population_specificity": "General discussion, no specific population studied.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.345604+00:00"}
{"study_id": 110505, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of soluble epoxide hydrolase (sEH) inhibition in increasing levels of beneficial lipid mediators derived from arachidonic acid and omega-3 PUFAs, and their potential therapeutic effects in metabolic diseases.", "results_summary": "The study found that EETs derived from arachidonic acid and omega-3 PUFA metabolites exhibit anti-inflammatory and vasodilatory effects, suggesting sEH inhibition as a potential therapeutic target for metabolic disorders like hypertension, atherosclerosis, and fatty liver disease.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.501434+00:00"}
{"study_id": 110503, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the predictive value of enhanced platelet responsiveness to dual antiplatelet therapy (including aspirin and clopidogrel) for bleeding after elective PCI, using arachidonic acid-induced platelet functional tests.", "results_summary": "The study found that lower MAE ADP test values after 24 hours were associated with higher bleeding incidence, suggesting arachidonic acid-induced platelet responsiveness could predict bleeding risk post-PCI. Female gender, previous myocardial infarction, lower body mass, and MAE ADP test results were independent predictors of bleeding.", "population_specificity": "481 elective PCI patients followed for an average of 15.34 \u00b1 7.19 months.", "effective_dosage": "Not specified", "study_duration": "24 hours post-PCI", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.970171+00:00"}
{"study_id": 110507, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the synthesis, biological activities, and potential therapeutic applications of 15-LOX inhibitors, including their role in metabolizing arachidonic acid.", "results_summary": "The study highlighted the role of 15-LOX enzymes in metabolizing arachidonic acid and their involvement in inflammation, atherosclerosis, and cancer, suggesting potential for 15-LOX inhibitors as future chemotherapy agents.", "population_specificity": "Mammals (general, not human-specific)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:19.087094+00:00"}
{"study_id": 110504, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers examined the antiplatelet effects of prasugrel/bivalirudin compared to clopidogrel/heparin, including the response to arachidonic acid as one of the agonists tested.", "results_summary": "The study found no significant inhibition of platelet aggregation in response to arachidonic acid in either treatment group at 3 or 72 hours. The prasugrel/bivalirudin group showed stronger inhibition of platelet adhesion to collagen under flow conditions.", "population_specificity": "Patients with ST-segment elevation myocardial infarction (26 clopidogrel/heparin, 25 prasugrel/bivalirudin, 20 controls).", "effective_dosage": "Not specified", "study_duration": "Measurements taken at 3 and 72 hours after drug administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:19.952496+00:00"}
{"study_id": 110508, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore how the Mediterranean diet, including its influence on the arachidonic acid cascade, affects inflammation and clinical disease progression in arthritis patients.", "results_summary": "The study suggests that the Mediterranean diet, particularly its n-3 polyunsaturated fatty acids, modulates the arachidonic acid cascade and immune cell activity, potentially benefiting arthritis patients by reducing inflammation and improving clinical outcomes.", "population_specificity": "Arthritis patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:20.225602+00:00"}
{"study_id": 110509, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived eicosanoids in physiological and pathological processes, particularly their involvement in neuropsychiatric disorders like schizophrenia, depression, bipolar disorder, and autism spectrum disorders.", "results_summary": "The study found that arachidonic acid metabolism via COX-2 produces biologically active compounds influencing synaptic plasticity and inflammation, with COX-2 inhibitors like celecoxib showing beneficial effects in early-stage schizophrenia, refractory depression, and bipolar depression. The COX/prostaglandin E pathway may also be implicated in autism spectrum disorders.", "population_specificity": "Individuals with neuropsychiatric disorders (schizophrenia, depression, bipolar disorder, autism spectrum disorders).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:23.908259+00:00"}
{"study_id": 110502, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolites in cerebral vascular function and stroke, and identify potential therapeutic targets for ischemic stroke and subarachnoid hemorrhage.", "results_summary": "The study found that arachidonic acid metabolites, particularly 20-HETE and EETs, play significant roles in cerebral vascular regulation and stroke pathology. Blocking 20-HETE or stabilizing EETs through sEH inhibition showed cerebroprotective effects against ischemic stroke and subarachnoid hemorrhage.", "population_specificity": "Animal models with targeted gene deletion and enzymatic inhibitors (not specified for humans).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.608847+00:00"}
{"study_id": 110512, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the mechanisms by which omega-3 PUFAs, including their interaction with arachidonic acid, contribute to cardioprotective effects.", "results_summary": "The study found that omega-3 PUFAs prevent the conversion of arachidonic acid into pro-inflammatory eicosanoids, leading to less potent inflammatory products. Additionally, omega-3 PUFAs modulate membrane ion channels and produce anti-inflammatory metabolites, which may contribute to cardiovascular benefits.", "population_specificity": "Patients with symptomatic heart failure or recent myocardial infarction, and the general population for CVD prevention.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:28.108786+00:00"}
{"study_id": 110513, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of resistance training combined with a healthy diet (low n-6/n-3 ratio) on muscle mass and inflammatory markers, including arachidonic acid, in older women.", "results_summary": "The study found a significant decrease in serum arachidonic acid levels (-5.3%) in the resistance training + healthy diet group, alongside increased n-3 docosahexaenoic acid, suggesting a shift in fatty acid metabolism. No changes in arachidonic acid were observed in the other groups.", "population_specificity": "Healthy, physically active older women aged 65-70 with low baseline inflammatory markers.", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:28.319347+00:00"}
{"study_id": 110514, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived endocannabinoids in metabolic disorders, particularly obesity, and investigate the potential of GPR18 as a therapeutic target.", "results_summary": "The study found that overweight and obese individuals have higher levels of arachidonic acid-derived endocannabinoids and altered cannabinoid receptor expression, suggesting a link to metabolic dysregulation. It also highlights GPR18's potential immunological function and its relevance in dietary regulation for metabolic disorders.", "population_specificity": "Overweight and obese individuals", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:28.768973+00:00"}
{"study_id": 110510, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the relationship between platelet aggregation responses, including those induced by arachidonic acid, following the cessation of clopidogrel treatment in patients with coronary stents.", "results_summary": "The study found that patients with early pronounced rebound effects after stopping clopidogrel exhibited long-term increased platelet aggregation in response to arachidonic acid (ASPI values), suggesting complex interactions among platelet agonists. Significant differences in ASPI values were observed 10 and 45 days post-cessation.", "population_specificity": "200 patients with coronary stent implantation treated with aspirin + clopidogrel for 1 year.", "effective_dosage": "Not specified", "study_duration": "1 year of clopidogrel treatment, with follow-up assessments up to 90 days post-cessation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:28.839621+00:00"}
{"study_id": 110511, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess whether platelet function testing using arachidonic acid (ASPI Test) could predict bleeding risk in patients undergoing coronary artery bypass grafting (CABG).", "results_summary": "The study found that an ASPI test value <407 AUC*min predicted higher postoperative drainage, while <271 AUC*min was linked to the need for red blood cell concentrate transfusion post-surgery. The ADP test (using adenosine diphosphate) did not show prognostic utility for bleeding risk in patients who stopped clopidogrel before surgery.", "population_specificity": "478 patients (mean age 65.2\u00b115.2 years, 138 women) undergoing CABG, including on-pump, off-pump, and minimally invasive surgeries, as well as valve implantation procedures.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:29.032960+00:00"}
{"study_id": 110515, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the immunomodulatory, anti-inflammatory, and physiological roles of arachidonic acid (AA) and other PUFAs, including their interactions with aspirin and other compounds.", "results_summary": "The study found that AA and other PUFAs modulate inflammation, immune response, and various biological processes, with aspirin enhancing the production of anti-inflammatory metabolites like lipoxin A4. These effects may underlie their role in physiological functions and disease management.", "population_specificity": "Not specified (general human physiological and pathological contexts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Aspirin enhances anti-inflammatory metabolites from AA; other NSAIDs may not share this effect.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:29.434898+00:00"}
{"study_id": 110516, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate temporal variability in platelet reactivity to clopidogrel and aspirin, including responses to arachidonic acid, in patients after elective PCI with drug-eluting stents.", "results_summary": "The study found considerable individual variation in platelet reactivity to clopidogrel over time, with high platelet reactivity (HPR) observed in 35-46% of patients. Platelet inhibition by aspirin, including responses to arachidonic acid, remained consistent over time with minimal HPR cases.", "population_specificity": "102 patients undergoing elective percutaneous coronary intervention (PCI) with drug-eluting stents.", "effective_dosage": "Not specified", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:32.693840+00:00"}
{"study_id": 110517, "supplement_id": 885, "safety_score": "60", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the balance between beneficial and harmful effects of arachidonic acid and how omega-3 nutrients can modulate its cascade activity.", "results_summary": "The study found that arachidonic acid has moderate physiological benefits but can shift to harmful effects if overactive, with omega-3 nutrients helping to widen its therapeutic window. It also highlighted the need to manage cascade overactivity to reduce reliance on drug treatments.", "population_specificity": "Not specified (general discussion of physiological mechanisms).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:34.050404+00:00"}
{"study_id": 110521, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the crosstalk between sphingomyelinase and cytosolic phospholipase A2 (cPLA2), including the role of arachidonic acid in neurological contexts.", "results_summary": "The abstract mentions crosstalk between sphingomyelinase and cPLA2, including arachidonic acid, but does not provide specific findings on its effects.", "population_specificity": "Neurons, neuronal progenitor cells, glial cells, and brain endothelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:36.691129+00:00"}
{"study_id": 110519, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate oxidative stress markers (F(2)-IsoPs derived from arachidonic acid) in TBI patients and assess the impact of sedatives (propofol vs. midazolam) on these markers.", "results_summary": "TBI patients showed elevated F(2)-IsoPs levels in CSF, indicating oxidative stress. Propofol treatment was associated with higher plasma F(2)-IsoPs and worse outcomes compared to midazolam, suggesting potential promotion of lipid peroxidation.", "population_specificity": "15 moderate and severe TBI patients, compared to 11 controls.", "effective_dosage": "Not specified", "study_duration": "72 hours postoperation, with sample collection for 6-10 days.", "interactions": "Propofol infusion may interact with lipid peroxidation pathways.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:37.925689+00:00"}
{"study_id": 110522, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of human CYP4 \u03c9-hydroxylases in metabolizing arachidonic acid-derived eicosanoids and their biological effects in inflammation and cancer progression.", "results_summary": "The study found that CYP4 enzymes, particularly CYP4A11, CYP4F2, and CYP4F3B, metabolize arachidonic acid to form 20-HETE, which influences tumor progression, angiogenesis, and blood pressure regulation. CYP4F3A inactivates leukotriene B4, regulating inflammatory responses.", "population_specificity": "Not specified (focus on enzymatic mechanisms in human tissues).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:38.484438+00:00"}
{"study_id": 110523, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of cytochrome P450 enzymes in metabolizing arachidonic acid into bioactive mediators with anti-inflammatory effects and their implications for drug efficacy and toxicity in inflammatory diseases.", "results_summary": "The study found that CYP2C and CYP2J epoxygenases convert arachidonic acid into anti-inflammatory epoxyeicosatrienoic acids, which have protective effects in cardiovascular disease and metabolic syndrome. CYP4A and CYP4F hydroxylases metabolize arachidonic acid into other bioactive compounds, but their physiological relevance varies.", "population_specificity": "Not specified (focus on enzymatic mechanisms and animal models/primary hepatocytes).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:38.768746+00:00"}
{"study_id": 110518, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare metabolic responses, including changes in arachidonic acid levels, between metabolically healthy obese (MHO), lean healthy (LH), and metabolically unhealthy obese (MUO) individuals after a high-calorie meal.", "results_summary": "Arachidonic acid showed smaller postprandial changes in MHO individuals compared to MUO individuals, suggesting a differential metabolic response. Fasting levels of certain fatty acids, including arachidonic acid, correlated with glucose and insulin responses.", "population_specificity": "Adults aged 35-70 years classified as LH, MHO, or MUO based on anthropometric and clinical measurements.", "effective_dosage": "Not specified (arachidonic acid levels were measured, not administered).", "study_duration": "Single meal intervention with measurements up to 120 minutes postprandially.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:38.999408+00:00"}
{"study_id": 110524, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the role of arachidonic acid as a signal distributer in COPD pathogenesis and its connection to lipid metabolism dysregulation.", "results_summary": "The study found that arachidonic acid is upregulated by the sphingolipid signaling pathway in COPD and acts as an early signal distributer, linking disease severity and hypoxia to metabolic disruptions. Hypoxia was also identified as a critical factor in shifting energy dependency to glucose.", "population_specificity": "Smokers with COPD, particularly those with emphysema, vascular disease, hypertension, and increased lung cancer risk.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:41.378655+00:00"}
{"study_id": 110525, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of PLA2s in liberating arachidonic acid (AA) and their potential as therapeutic targets for cancer and inflammatory disorders.", "results_summary": "The study found that PLA2s, particularly Group IVA cPLA2, play a key role in cancer and inflammation, and isoform-specific PLA2 inhibitors are under clinical trials for these conditions. The role of AA liberation by PLA2s in disease pathology was highlighted, but its direct effects were not detailed.", "population_specificity": "Not specified (focus on enzymatic mechanisms and disease models).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:42.445513+00:00"}
{"study_id": 110526, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the time-course and associations of high on-treatment platelet reactivity (HPR) by arachidonic acid and ADP in acute coronary syndrome patients.", "results_summary": "The study found that persistent HPR by arachidonic acid was more common in diabetic patients, while late HPR was associated with increased immature platelet fraction. About 25% of patients exhibited persistent HPR, linked to diabetes, overweight, or CYP2C19*2 carrier status.", "population_specificity": "Male acute coronary syndrome patients (n=101).", "effective_dosage": "Platelet aggregation measured using 1mmol arachidonic acid.", "study_duration": "Evaluated at acute phase (T0), 6 months (T1), and 1 year (T2).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:45.760189+00:00"}
{"study_id": 110528, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 74, "quality_score": 85, "study_goal": "The researchers aimed to determine whether dysregulated arachidonic acid (AA) levels in human serum could serve as a biomarker for detecting age-related macular degeneration (AMD).", "results_summary": "The study found that AA levels were approximately 32% higher in AMD patients compared to healthy individuals, and a statistical model incorporating AA and DHA levels had a 74% probability of correctly identifying AMD patients.", "population_specificity": "Patients with age-related macular degeneration (AMD) and healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:46.520337+00:00"}
{"study_id": 110527, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate whether reduced levels of arachidonic acid in patients receiving olive oil-based lipid emulsions indicated essential fatty acid deficiency (EFAD).", "results_summary": "The study found that despite reduced linoleic acid and elevated Mead acid levels, the triene/tetraene ratio (Mead acid/arachidonic acid) remained below the threshold indicating EFAD, suggesting adequate arachidonic acid levels were maintained. The fatty acid profiles reflected the composition of the lipid emulsion but did not show deficiency.", "population_specificity": "Three complicated obese patients receiving parenteral nutrition with ClinOleic 20%.", "effective_dosage": "Not specified", "study_duration": "Throughout hospital admission (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:46.901976+00:00"}
{"study_id": 110530, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review evidence suggesting that BoNT/A has effects beyond its known mechanism of SNAP-25 cleavage, including potential antimitotic and antitumor activities.", "results_summary": "The study found that BoNT/A may act through unknown molecular targets and signaling pathways, independent of SNAP-25 cleavage, with potential pharmacological significance, including antimitotic and antitumor effects.", "population_specificity": "Not specified (in vitro and in vivo findings reviewed)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:47.268436+00:00"}
{"study_id": 110529, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to assess the effects of dabigatran and rivaroxaban on platelet reactivity, including response to arachidonic acid, in patients with non-valvular atrial fibrillation.", "results_summary": "The study found no significant differences in platelet reactivity or systemic inflammation markers between baseline and on-treatment periods, though there was a trend toward increased platelet reactivity in response to arachidonic acid, likely due to aspirin discontinuation in some patients.", "population_specificity": "Patients with non-valvular atrial fibrillation (mean age 69-73 years, 20-35% women, mean CHADS2 score 2.6-2.7).", "effective_dosage": "Not specified", "study_duration": "At least 7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:47.460684+00:00"}
{"study_id": 110520, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether topical or oral diclofenac interfered with the antiplatelet effects of aspirin, as measured by platelet responsiveness to arachidonic acid (AA).", "results_summary": "The study found no significant interference with aspirin's antiplatelet effects when using the topical diclofenac patch, but oral diclofenac reduced platelet inhibition at specific time points. Arachidonic acid was used as a measure of platelet function, but its direct effects were not the primary focus.", "population_specificity": "12 healthy men and women aged 18-50.", "effective_dosage": "Arachidonic acid 0.5 mM (used in platelet function testing).", "study_duration": "Not specified (measurements taken every 2 hours).", "interactions": "Oral diclofenac reduced aspirin's antiplatelet effects at hour 2 and hour 8; topical diclofenac showed no significant interaction.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:49.519171+00:00"}
{"study_id": 110531, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to examine the effects of rosuvastatin and pitavastatin on serum levels of arachidonic acid (AA) and other PUFAs in patients with dyslipidemia.", "results_summary": "The study found that serum arachidonic acid (AA) levels did not change significantly with either statin treatment, though the DHA/AA ratio decreased. No adverse events related to AA were reported.", "population_specificity": "46 patients with dyslipidemia not receiving lipid-lowering therapy.", "effective_dosage": "Not specified for AA (study focused on statins: 2.5 mg/day rosuvastatin or 2 mg/day pitavastatin).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:51.777965+00:00"}
{"study_id": 110532, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the influence of HbA1c levels on platelet aggregation and turnover in CAD patients, particularly focusing on the antiplatelet effect of aspirin in relation to arachidonic acid.", "results_summary": "The study found that CAD patients with type 2 diabetes and prediabetes had higher platelet aggregation when exposed to arachidonic acid, indicating a potential attenuation of aspirin's antiplatelet effect. Increased HbA1c levels weakly correlated with elevated platelet aggregation, turnover, and activation, particularly in non-diabetic and prediabetic patients.", "population_specificity": "865 stable CAD patients (242 with type 2 diabetes, 303 with prediabetes, and 320 without diabetes).", "effective_dosage": "Not specified (aspirin dosage was 75 mg as monotherapy).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:53.638747+00:00"}
{"study_id": 110533, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers sought to determine the association of dietary intake and supplementation of arachidonic acid (an omega-6 fatty acid) with inflammation and functional capacity in people with COPD.", "results_summary": "The study found inconsistent associations between dietary omega-3 fatty acids and inflammation in COPD patients, with no specific conclusions drawn about arachidonic acid's effects. Limited evidence supported omega-3 supplementation for improving functional capacity, but no clear findings were reported for omega-6 fatty acids like arachidonic acid.", "population_specificity": "250 COPD patients in Spain (cross-sectional study) and 80 COPD patients in the Netherlands (randomized controlled trial).", "effective_dosage": "Not specified for arachidonic acid.", "study_duration": "8 weeks (for the RCT).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:54.994386+00:00"}
{"study_id": 110534, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent research on the genetic and molecular basis of NSAID-induced hypersensitivity reactions, including the role of prostaglandin, leukotriene-related genes, and pathways beyond arachidonic acid.", "results_summary": "The study found that the full genetic and molecular basis of NSAID hypersensitivity remains unclear, with no clinically proven genetic markers identified despite advances in high-throughput approaches like genome-wide association studies and next-generation sequencing. Future research directions include leveraging bioinformatics, systems biology, and precise patient phenotyping.", "population_specificity": "Not specified (focus on genetic and molecular research, not a specific demographic).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:55.116993+00:00"}
{"study_id": 110535, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare two methods (urinary 11dhTXB2 and AA-induced platelet aggregation) for assessing aspirin response and their clinical significance in predicting cardiovascular events in elderly CAD patients.", "results_summary": "The study found poor correlation and agreement between the two methods for classifying high-on aspirin platelet reactivity (HAPR). HAPR diagnosed by AA-induced platelet aggregation was associated with higher cardiovascular event rates, while HAPR determined by urinary 11dhTXB2 did not correlate with outcomes.", "population_specificity": "Elderly Chinese patients with coronary artery disease (CAD).", "effective_dosage": "0.5 mg/ml arachidonic acid (AA) for platelet aggregation assay.", "study_duration": "Mean follow-up time of 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:56.383357+00:00"}
{"study_id": 110536, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate how APOE4 genotype and BMI influence plasma fatty acid responses, including arachidonic acid, to a DHA-rich supplement in individuals consuming a high-saturated fat diet.", "results_summary": "The study found significant BMI \u00d7 genotype interactions for changes in plasma arachidonic acid concentrations, with APOE4 carriers showing lower responses to the DHA supplement, particularly in the high-BMI group.", "population_specificity": "41 APOE4 carriers and 41 noncarriers, stratified by BMI (low BMI <25.5, high BMI \u226525.5).", "effective_dosage": "3.45 g DHA/day and 0.5 g EPA/day.", "study_duration": "8 weeks of HSF diet followed by 8 weeks of HSF + DHA diet.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:57.312561+00:00"}
{"study_id": 110538, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to compare different platelet aggregation tests (LTA, VerifyNow, MEA) with flow cytometry for assessing platelet reactivity to arachidonic acid (AA) and ADP in patients on antiplatelet therapy.", "results_summary": "The study found poor correlation between AA-induced platelet reactivity measured by different aggregation tests and flow cytometry, suggesting these methods capture different aspects of platelet function. ADP-induced reactivity showed better but still partial correlation between aggregometry and flow cytometry.", "population_specificity": "316 patients receiving aspirin and clopidogrel therapy after angioplasty with stent implantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:58.021220+00:00"}
{"study_id": 110537, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of arachidonic acid derivatives in oxidative stress and preeclampsia, and explore Vitamin D3's potential as a competitive inhibitor of placental cytochrome P450scc to mitigate these effects.", "results_summary": "The study found that urinary levels of 15-F(2t)-isoprostane (an arachidonic acid derivative) were significantly higher in preeclamptic patients, suggesting enhanced oxidative stress. It proposed that Vitamin D3 might competitively inhibit placental cytochrome P450scc, reducing lipid peroxide production linked to preeclampsia.", "population_specificity": "74 pregnant women (43 with severe preeclampsia).", "effective_dosage": "Not specified for arachidonic acid; high-dose Vitamin D3 was mentioned but dosage not detailed.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:58.176560+00:00"}
{"study_id": 110539, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid derivatives in physiological modulation, inflammation, hemostasis, and cell proliferation, particularly in atherosclerosis and acute thrombotic events.", "results_summary": "The abstract highlights the complex involvement of arachidonic acid derivatives in cardiovascular effects and inflammation, noting potential hazards from prostanoid-altering drugs, but does not provide specific study results on arachidonic acid itself.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:59.028595+00:00"}
{"study_id": 110542, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine how dietary intake of omega-3 and omega-6 nutrients affects the proportion of arachidonic acid in human tissue lipids and its clinical implications.", "results_summary": "The study found that the proportion of arachidonic acid in human blood samples varies widely (30%-70% of HUFA) depending on dietary omega-3 and omega-6 intake, and significant clinical outcome differences were observed when dietary interventions shifted this balance sufficiently.", "population_specificity": "General human population with varying dietary omega-3 and omega-6 intakes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:03.056148+00:00"}
{"study_id": 110541, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the pharmacological properties of GPR40 and its functions in the brain, particularly in neurodevelopment and neurogenesis, as well as its involvement in neuropathological conditions.", "results_summary": "The study found that GPR40, when binding with PUFAs like Arachidonic Acid, shows therapeutic potential in neurodevelopment, neurogenesis, and addressing neuropathological conditions such as Alzheimer's and Parkinson's disease, though further research is needed.", "population_specificity": "Not specified (general focus on human brain regions and neuropathological conditions).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:03.423150+00:00"}
{"study_id": 110540, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of dietary \u03c9-3 PUFAs (including Arachidonic Acid) on visual acuity and RBC fatty acid composition in children with lower IQs or ADHD.", "results_summary": "The study found that Arachidonic Acid (C20:4 \u03c9-6) levels were significantly lower in the \u03c9-3 PUFA intervention group compared to the control group, suggesting a shift in fatty acid metabolism favoring \u03c9-3 PUFAs. No significant differences were found in other \u03c9-6 fatty acids, indicating selective modulation of Arachidonic Acid levels.", "population_specificity": "School-age children with lower IQs or ADHD.", "effective_dosage": "Not specified (intervention was eggs rich in \u03c9-3 PUFAs).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:04.160372+00:00"}
{"study_id": 110543, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of cytochrome P450 enzymes in metabolizing arachidonic acid and other PUFAs, and how dietary intake influences CYP eicosanoid profiles and associated health outcomes.", "results_summary": "The study found that CYP enzymes metabolize arachidonic acid into distinct eicosanoids, which regulate cardiovascular, renal, and inflammatory processes. Imbalances in these metabolites are linked to diseases like hypertension and myocardial infarction, suggesting potential therapeutic targets.", "population_specificity": "Mammalian tissues (not human-specific).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.381889+00:00"}
{"study_id": 110545, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of varying doses of DHA supplementation on blood DHA and arachidonic acid (AA) levels in preterm infants.", "results_summary": "The study found that DHA supplementation maintained blood DHA levels but did not affect AA levels. No adverse effects on feeding tolerance were observed.", "population_specificity": "Preterm infants born at less than 30 weeks' gestational age.", "effective_dosage": "40, 80, or 120 mg/kg/day of DHA.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.991326+00:00"}
{"study_id": 110544, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the pharmacodynamics and pharmacokinetics of extended-release (ER) and immediate-release (IR) acetylsalicylic acid (ASA) formulations, focusing on their antiplatelet effects and systemic drug concentrations.", "results_summary": "Both ER-ASA and IR-ASA showed dose-dependent inhibition of thromboxane B2 (TXB2) and platelet aggregation, with ER-ASA requiring approximately twice the dose of IR-ASA for similar effects. ER-ASA demonstrated prolonged absorption and lower peak systemic concentrations compared to IR-ASA.", "population_specificity": "Healthy adults (n = 50)", "effective_dosage": "ER-ASA up to 325 mg and IR-ASA up to 81 mg, single doses", "study_duration": "Four periods, each separated by \u226514 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:06.852270+00:00"}
{"study_id": 110546, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) in very low birth weight infants improves long-term cognitive function and neuroanatomical development.", "results_summary": "The study found no significant differences in cognitive measures or neuroanatomical outcomes (brain volumes, cortex volume, area, thickness) between the intervention and control groups at 8 years of age.", "population_specificity": "Very low birth weight (VLBW) infants fed human milk.", "effective_dosage": "0.91% AA and 0.86% DHA supplementation.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.329141+00:00"}
{"study_id": 110547, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of intravenous lysine acetylsalicylate (LA) versus oral aspirin on platelet inhibition in prasugrel-treated individuals, specifically assessing arachidonic acid-induced platelet aggregation.", "results_summary": "Intravenous LA achieved significantly higher and faster inhibition of platelet aggregation with arachidonic acid compared to oral aspirin at 30 minutes, 1 hour, and 4 hours, though the effect was not sustained at 24 hours. LA also showed less variability in platelet inhibition.", "population_specificity": "30 healthy volunteers", "effective_dosage": "Arachidonic acid 1.5 mmol/L (used for testing platelet aggregation)", "study_duration": "Evaluated at 30 minutes, 1 h, 4 h, and 24 h post-intervention", "interactions": "Prasugrel (P2Y12-adenosine diphosphate receptor antagonist)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:09.185747+00:00"}
{"study_id": 110548, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate changes in platelet reactivity, including response to arachidonic acid (AA), in subclinical hypothyroidism (SH) patients before and after levothyroxine (L-T4) treatment.", "results_summary": "SH patients showed increased platelet reactivity to AA at baseline, which significantly decreased after 6 months of L-T4 therapy, indicating improved hemostatic function. The reduction in AA-induced platelet aggregation was statistically significant (P < 0.001), suggesting L-T4 treatment effectively normalized platelet function.", "population_specificity": "Subclinical hypothyroidism patients without prior or ongoing L-T4 therapy.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:11.334432+00:00"}
{"study_id": 110549, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to review the role of abnormal arachidonic acid metabolism in the pathogenesis of aspirin-exacerbated respiratory disease and discuss its characteristics and treatment.", "results_summary": "The abstract highlights that abnormal arachidonic acid metabolism is a key feature in aspirin-exacerbated respiratory disease, but it does not provide specific findings on arachidonic acid's effects. The treatment discussed is aspirin desensitization and daily aspirin therapy, not arachidonic acid itself.", "population_specificity": "Patients with aspirin-exacerbated respiratory disease (chronic rhinosinusitis with nasal polyposis, asthma, and intolerance to COX-1 inhibiting drugs).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:12.212422+00:00"}
{"study_id": 110550, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine the incidence of aspirin resistance in infants after stage 1 single-ventricle palliation and whether increasing the aspirin dose could overcome this resistance.", "results_summary": "The study found a high incidence (80%) of aspirin resistance in infants post-surgery, with no patients achieving adequate platelet inhibition. Doubling the aspirin dose did not improve resistance, though some response was observed compared to baseline.", "population_specificity": "Infants with single-ventricle physiology requiring surgical palliation (Norwood/Sano, Norwood/BT shunt, or BT shunt alone).", "effective_dosage": "20 mg/day initially, increased to 40 mg/day for resistant patients.", "study_duration": "10 days (5 days at initial dose, 5 days at doubled dose for resistant patients).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:13.714401+00:00"}
{"study_id": 110551, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of PUFAs, including arachidonic acid, and COXIBs in inflammation, tumorigenesis, and cancer treatment.", "results_summary": "The study found that \u03c9-6 PUFAs like arachidonic acid promote cancer cell growth, angiogenesis, and invasion, while \u03c9-3 PUFAs may suppress its proinflammatory effects. COXIBs modulate inflammation by inhibiting COX-2, suggesting a synergistic therapeutic approach for cancer.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:13.909562+00:00"}
{"study_id": 110552, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid-derived lipid mediators (lipoxins and aspirin-triggered lipoxins) in regulating inflammation and promoting resolution.", "results_summary": "The study found that lipoxins (LX) and aspirin-triggered lipoxins (ATL) derived from arachidonic acid exhibit potent anti-inflammatory and pro-resolution effects in leukocytes, vascular, and epithelial cells. These mediators showed benefits in preclinical models and some clinical trials by activating the ALX/FPR2 receptor.", "population_specificity": "Not specified (preclinical models and some clinical trials mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:14.451546+00:00"}
{"study_id": 110554, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate short-term changes in platelet function, including response to Arachidonic Acid, during hip arthroplasty.", "results_summary": "Platelet response to Arachidonic Acid (ASPItest) demonstrated a pattern of initial decrease followed by increased responsiveness during surgery, similar to other agonists tested. The study noted satisfactory assay reliability with minimal re-runs.", "population_specificity": "Patients undergoing primary cemented hip arthroplasty.", "effective_dosage": "Not specified", "study_duration": "Peri-operative period (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:14.870087+00:00"}
{"study_id": 110553, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the role of PLA2 inhibitors, including those affecting arachidonic acid metabolism, in treating oxidative stress and neuroinflammation associated with neurological disorders.", "results_summary": "The study highlights that arachidonic acid-derived lipid mediators play critical roles in neuroinflammation and oxidative stress, and various synthetic and plant-based PLA2 inhibitors show potential for treating neurological disorders in cell culture and animal models.", "population_specificity": "Cell culture and animal model systems (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:14.941812+00:00"}
{"study_id": 110557, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid in platelet activation and its interaction with reactive oxidant species (ROS) in the context of cardiovascular diseases.", "results_summary": "The study found that arachidonic acid interacts with ROS to form isoprostanes, contributing to platelet activation, and that inhibiting Nox2 (a source of ROS) reduces platelet activation and ROS production.", "population_specificity": "Patients with systemic atherosclerosis and cardiovascular diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:19.383555+00:00"}
{"study_id": 110556, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid (AA) derivatives in inflammation resolution and the influence of EPA and DHA supplementation on disease outcomes.", "results_summary": "The study found that not all AA derivatives are proinflammatory, with lipoxins and epi-lipoxins showing anti-inflammatory properties. However, clinical trials on EPA and DHA supplementation yielded mixed results, preventing clear guidelines.", "population_specificity": "Not specified (general discussion of mechanisms and clinical trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Prescription drugs may influence eicosanoid synthesis, potentially affecting trial outcomes.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:19.491093+00:00"}
{"study_id": 110558, "supplement_id": 885, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy and tolerability of verbascoside in modulating platelet aggregation values in subjects with cardiovascular risk factors, using arachidonic acid (AA) as one of the stimuli.", "results_summary": "Verbascoside 100mg significantly reduced platelet aggregation values after AA and ADP stimuli, while lower doses (50mg) and placebo showed no effect. No serious adverse events were reported.", "population_specificity": "Subjects with at least one cardiovascular risk factor (age >65, diabetes, hypertension, smoking, hyperlipidemia, or elevated waist circumference).", "effective_dosage": "50mg and 100mg verbascoside.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:21.939581+00:00"}
{"study_id": 110560, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived leukotrienes in immune cell recruitment, plaque inflammation, and atherosclerosis progression.", "results_summary": "The study found that leukotrienes derived from arachidonic acid contribute to immune cell recruitment, smooth muscle cell proliferation, and endothelial dysfunction in atherosclerotic plaques, but antileukotrienes showed potential in reducing experimental atherosclerosis.", "population_specificity": "Not specified (focused on experimental atherosclerosis models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.239507+00:00"}
{"study_id": 110562, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to identify differentially expressed genes and biological processes, including arachidonic acid metabolism, associated with anthracycline resistance in breast cancer cells.", "results_summary": "The study found that arachidonic acid metabolism was one of the significant pathways related to anthracycline resistance in breast cancer cells, but it did not directly assess the effects of arachidonic acid supplementation.", "population_specificity": "Human breast cancer cell lines with acquired anthracycline resistance.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.446151+00:00"}
{"study_id": 110559, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers investigated whether moderate DHA supplementation could correct platelet dysfunction and redox imbalance in patients with type 2 diabetes, focusing on markers of arachidonic acid metabolism.", "results_summary": "DHA supplementation reduced platelet aggregation, decreased thromboxane B2 and F2-isoprostane levels, and increased vitamin E concentrations, indicating improved platelet function and reduced oxidative stress. No effects were observed after placebo treatment.", "population_specificity": "Post-menopausal women with type 2 diabetes (n=11)", "effective_dosage": "400 mg/day of DHA", "study_duration": "Two weeks per intervention period, with a six-week washout between periods", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.508261+00:00"}
{"study_id": 110561, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether responses to antiplatelet therapy, including arachidonic acid-mediated platelet aggregation, vary significantly over time in patients receiving dual-antiplatelet therapy.", "results_summary": "The study found that arachidonic acid-mediated platelet aggregation increased at 1 week compared to predischarge, indicating variability in response to antiplatelet therapy. No significant changes were observed beyond 1 week.", "population_specificity": "40 patients receiving dual-antiplatelet therapy (aspirin and clopidogrel) after hospital discharge for acute coronary syndrome or intracoronary stents.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.936967+00:00"}
{"study_id": 110555, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the lipid compositions of breast milk and infant formulae, including arachidonic acid, and their potential biological and health effects in infants.", "results_summary": "The study highlighted differences in unsaturated fatty acids, including arachidonic acid, between breast milk and infant formulae but noted that the functional outcomes of these differences remain largely unknown. Opportunities for improving lipid supply through diet or formulae were identified, but further research is needed.", "population_specificity": "Term and preterm infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:28.071849+00:00"}
{"study_id": 110564, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers compared the effects of febuxostat and allopurinol on the eicosapentaenoic acid/arachidonic acid ratio and other biomarkers in cardiac surgery patients with chronic kidney disease.", "results_summary": "The study found that febuxostat significantly improved the eicosapentaenoic acid/arachidonic acid ratio compared to allopurinol, along with other beneficial effects on oxidative stress and inflammation markers.", "population_specificity": "Cardiac surgery patients with chronic kidney disease (eGFR \u226460 mL/min/1.73 m\u00b2 or stage 3 CKD).", "effective_dosage": "Not specified", "study_duration": "At least 1 month (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:28.260319+00:00"}
{"study_id": 110563, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to analyze the prevalence of nonresponse to dual antiplatelet therapy, including arachidonic acid-induced platelet aggregation inhibition, in patients with critical limb ischemia following stent thrombosis.", "results_summary": "The study found that effective aspirin-induced inhibition of platelet aggregation (via arachidonic acid stimulation) was confirmed in 78% of patients, indicating moderate efficacy. However, 14% of patients showed nonresponse to both antiaggregatory drugs.", "population_specificity": "Patients with critical limb ischemia following stent thrombosis on dual antiplatelet therapy (aspirin and clopidogrel).", "effective_dosage": "100 mg aspirin per day (arachidonic acid stimulation via ASPItest).", "study_duration": "Three months prior to enrollment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:28.683711+00:00"}
{"study_id": 110565, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of clopidogrel and ASA (including arachidonic acid stimulation) in inhibiting platelet function in patients with and without type-2 diabetes.", "results_summary": "The study found that arachidonic acid (ASPI test) showed significantly less platelet inhibition in diabetic patients compared to non-diabetics (p = 0.022), indicating reduced efficacy of ASA in diabetic subjects.", "population_specificity": "64 patients with stable coronary artery disease (32 with type-2 diabetes, 32 non-diabetic controls).", "effective_dosage": "100 mg ASA per day.", "study_duration": "Not specified (blood samples taken 24h after intervention).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:30.494801+00:00"}
{"study_id": 110567, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of a high-oleic RUTF (HO-RUTF) versus standard RUTF on the plasma phospholipid fatty acid status, including arachidonic acid, in children with severe acute malnutrition.", "results_summary": "The study found that arachidonic acid content decreased by 3% in the HO-RUTF group but increased by 13% in the standard RUTF group, with a statistically significant difference (P < 0.009).", "population_specificity": "Rural Malawian children with severe acute malnutrition.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:30.692951+00:00"}
{"study_id": 110569, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with n-3 PUFAs (including arachidonic acid precursors) influences the production of SPMs and cognitive function in Alzheimer's disease patients.", "results_summary": "Supplementation with n-3 PUFAs prevented a reduction in SPMs (lipoxin A4 and resolvin D1) released from PBMCs, which was associated with cognitive changes. Plasma levels of arachidonic acid decreased, while DHA and EPA levels increased after treatment.", "population_specificity": "Alzheimer's disease patients", "effective_dosage": "1.7 g DHA and 0.6 g EPA daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:31.283253+00:00"}
{"study_id": 110568, "supplement_id": 885, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Arachidonic Acid (ARA) in treating Schistosoma mansoni infections in schoolchildren from high-endemicity regions, both alone and in combination with praziquantel (PZQ).", "results_summary": "ARA showed moderate cure rates (50% for light infections, 21% for heavy infections), comparable to PZQ, but the combination of ARA and PZQ achieved higher cure rates (83% for light infections, 78% for heavy infections). Biochemical and immunological profiles remained stable or improved after ARA therapy.", "population_specificity": "Schoolchildren with light, moderate, or heavy Schistosoma mansoni infections in high-endemicity areas of Kafr El Sheikh, Egypt.", "effective_dosage": "10 mg/kg per day for 15 days (ARA), 40 mg/kg single dose (PZQ).", "study_duration": "15 days (ARA), single dose (PZQ).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:32.730736+00:00"}
{"study_id": 110571, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to improve the quantification of eicosanoids and oxylipins derived from arachidonic acid (AA) to better understand their biology and monitor pharmaceutical and dietary interventions.", "results_summary": "The study highlights challenges in quantifying AA-derived oxylipins, including low concentrations, structural similarities, and the need for advanced analytical methods. It identifies issues with sample handling, degradation, and the detection of esterified oxylipins as key obstacles.", "population_specificity": "Not specified (focus on analytical methods, not human subjects).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:36.790971+00:00"}
{"study_id": 110572, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolites, among other inflammatory mediators, in the progression of atherosclerosis, particularly focusing on mast cell activation and its implications.", "results_summary": "The abstract highlights that arachidonic acid metabolites are released by mast cells during atherosclerotic plaque progression, contributing to inflammation and vascular remodeling, but does not provide specific efficacy data on arachidonic acid itself.", "population_specificity": "Not specified (general focus on atherosclerosis mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:37.249528+00:00"}
{"study_id": 110570, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to investigate the inhibitory effects of valsartan on arachidonic acid-induced platelet aggregation and its role in reducing cardio-cerebral thrombotic events in elderly hypertensive patients.", "results_summary": "Valsartan significantly reduced platelet aggregation induced by arachidonic acid, lowered plasma levels of COX-2 and TXB2, and decreased thrombotic event rates compared to amlodipine. The study also found that valsartan attenuated COX-2/TXA2 expression via p38MAPK and NF-kB pathways in human aortic endothelial cells.", "population_specificity": "Elderly patients (>60 years) with hypertension.", "effective_dosage": "Not specified for arachidonic acid (valsartan dosage: 100 nmol/L in vitro).", "study_duration": "Median follow-up of 18 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:37.270361+00:00"}
{"study_id": 110574, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid derivatives in activating TRP channels and their potential as therapeutic targets for chronic cough.", "results_summary": "The abstract suggests that arachidonic acid derivatives are among the activators of TRP channels, which are implicated in chronic cough, but does not provide specific efficacy or safety data on arachidonic acid itself.", "population_specificity": "Not specified (focus is on general mechanisms in airway disease).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:38.943820+00:00"}
{"study_id": 110573, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the synthesis, biological function, and relevance of leukotrienes derived from arachidonic acid in allergic diseases and explore therapeutic prospects of LT modifiers.", "results_summary": "The abstract highlights that leukotrienes derived from arachidonic acid play a central role in inflammatory disorders like asthma, acting as chemoattractants and bronchoconstrictors, but does not provide specific efficacy or safety data on arachidonic acid itself.", "population_specificity": "Not specified (review of general biological and pathological mechanisms)", "effective_dosage": "Not available", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:39.018001+00:00"}
{"study_id": 110576, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of COX activity and prostaglandins derived from arachidonic acid on allergic airway inflammation and asthma.", "results_summary": "The study reviewed how different prostaglandins influence allergic airway inflammation and asthma, highlighting their potential therapeutic benefits based on basic science, animal models, and human studies. Some prostaglandins may counteract others or have opposing effects depending on receptor signaling.", "population_specificity": "Not specified (review of basic science, animal models, and human studies).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:40.425168+00:00"}
{"study_id": 110566, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether vortioxetine affects the pharmacodynamics of arachidonic acid-induced platelet aggregation.", "results_summary": "The study found that vortioxetine had no statistically significant effect on arachidonic acid-induced platelet aggregation at any time points. Coadministration of vortioxetine did not alter the pharmacokinetics or pharmacodynamics of aspirin or warfarin.", "population_specificity": "Healthy volunteers", "effective_dosage": "Not specified for arachidonic acid (aspirin dose: 150 mg once daily)", "study_duration": "6 days (aspirin coadministration period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:40.671818+00:00"}
{"study_id": 110575, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of dysregulated arachidonic acid metabolism in aspirin-exacerbated respiratory disease (AERD) and its impact on chronic rhinosinusitis with nasal polyps (CRSwNP).", "results_summary": "The study found that arachidonic acid metabolism is dysregulated in AERD, leading to PGE\u2082 resistance, overproduction of cysteinyl leukotrienes (CysLTs), and cellular stimulation by INF-\u03b3 from eosinophils. Aspirin desensitization may help reduce cytokine levels and improve symptoms in AERD patients with CRSwNP.", "population_specificity": "Patients with aspirin-exacerbated respiratory disease (AERD) and chronic rhinosinusitis with nasal polyps (CRSwNP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:40.820429+00:00"}
{"study_id": 110579, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the mechanisms of glucocorticoid (GC) action, including their effects on arachidonic acid metabolites, and explore GC resistance in chronic inflammatory conditions.", "results_summary": "The abstract indicates that GCs inhibit arachidonic acid metabolites, among other inflammatory mediators, as part of their anti-inflammatory mechanism. However, the study does not specifically evaluate the efficacy or safety of arachidonic acid itself.", "population_specificity": "Chronic inflammatory patients (e.g., rheumatic diseases, allergy, asthma, sepsis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:45.100048+00:00"}
{"study_id": 110577, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of \u03c9-3 fatty acids, which influence arachidonic acid-derived inflammatory mediators, on clinical outcomes in ARDS patients.", "results_summary": "The study found mixed results, with some trials reporting clinical benefits, others no effect, and one showing negative impact. Meta-analysis indicated no overall effect on ventilator-free or ICU-free days, but a small reduction in ICU stay and no effect on mortality, with outcomes influenced by fat content differences between treatment and control formulas.", "population_specificity": "Patients with acute respiratory disease syndrome (ARDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:45.168793+00:00"}
{"study_id": 110578, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of fish oil-containing lipid emulsions rich in \u03c9-3 fatty acids, including arachidonic acid, for parenteral nutrition in preterm neonates.", "results_summary": "The study found that arachidonic acid levels in plasma and red blood cell membranes were significantly lower in the fish oil group compared to controls, but no differences were observed in clinical outcomes like body weight, bilirubin levels, or mortality. The safety implications of these changes remain unclear.", "population_specificity": "Preterm neonates", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:46.398091+00:00"}
{"study_id": 110581, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the metabolic pathways and biological roles of specific arachidonic acid derivatives, focusing on their implications in diseases like asthma, cancer, and diabetes.", "results_summary": "The study found that arachidonic acid derivatives (e.g., 5-oxo-ETE, 12S-HETE) play roles in promoting inflammation, tumor proliferation, and metastasis, while 15S-HETE may have protective effects in cancer. Selective receptor antagonists for these metabolites could have therapeutic potential.", "population_specificity": "Not specified (review of biochemical and pathophysiological mechanisms).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:47.307872+00:00"}
{"study_id": 110580, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid (an n-6 LC-PUFA) in perinatal development and its associations with later health outcomes such as body weight, allergic diseases, and cognitive performance.", "results_summary": "The study found that arachidonic acid, along with other LC-PUFAs, influences neural cell growth, adipocyte differentiation, and regulatory T-cell function, but randomized trials have not yet established optimal intake levels. Some evidence suggests benefits for visual function and asthma risk with higher docosahexaenoic acid (an n-3 LC-PUFA) status.", "population_specificity": "Pregnant women and infants (perinatal period).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:48.236228+00:00"}
{"study_id": 110582, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review recent developments in the study of isoprostanes (IsoPs), particularly their role as biomarkers and mediators of oxidative stress, with a focus on clinical research.", "results_summary": "The study highlights that IsoPs, derived from arachidonic acid and other polyunsaturated fatty acids, serve as biomarkers and mediators of oxidative stress in various diseases, including obesity, ischemia-reperfusion injury, and cancer. It also notes the influence of diet and lifestyle on endogenous IsoP levels.", "population_specificity": "Humans (clinical research focus, no specific subpopulation detailed)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:48.542122+00:00"}
{"study_id": 110583, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of CYP P450 metabolites of arachidonic acid (20-HETE and EETs) in regulating renal function, blood pressure, and kidney diseases.", "results_summary": "The study found that 20-HETE and EETs play key roles in regulating blood pressure, renal injury, and kidney diseases, with 20-HETE deficiency linked to hypertension and renal injury, while EETs showed renoprotective properties and blood pressure-lowering effects.", "population_specificity": "Humans and rodent models (Dahl S rats).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:48.782542+00:00"}
{"study_id": 110584, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid and other PUFAs in brain function, including neurotransmission, cell survival, and neuroinflammation, and their potential implications for neurological disorders.", "results_summary": "The study found that arachidonic acid and its mediators regulate key brain processes like neurotransmission and neuroinflammation, with altered levels and signaling pathways observed in neurological disorders such as Alzheimer's disease and major depression. It suggests that dietary and pharmacological targeting of PUFAs could offer novel therapeutic approaches for brain disorders.", "population_specificity": "General brain function and neurological disorders (e.g., Alzheimer's disease, major depression)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:49.252774+00:00"}
{"study_id": 110586, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify genetic polymorphisms influencing platelet aggregation during aspirin treatment, using arachidonic acid as an agonist to assess platelet function.", "results_summary": "The study found that the A-allele of the rs12041331 SNP in the PEAR1 gene was associated with reduced platelet aggregation when arachidonic acid was used as an agonist, but other SNPs did not affect aggregation. The mechanism may involve changes in platelet activation rather than cyclooxygenase-1 activity.", "population_specificity": "985 Danish patients with stable coronary artery disease on aspirin 75 mg/day mono antiplatelet therapy.", "effective_dosage": "Not specified for arachidonic acid (used as an agonist in testing).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:53.434466+00:00"}
{"study_id": 110587, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the effects of arachidonic acid metabolites (prostanoids) on their synthesis, activity, degradation, and their role in inflammation and tumor progression.", "results_summary": "The study found that arachidonic acid metabolites, particularly 15-deoxy-\u0394(12,14)-prostaglandin J\u2082, play a significant role in regulating prostanoid synthesis and act as anti-inflammatory agents. It also highlighted interactions between thromboxane A\u2082 and prostaglandin I\u2082 receptors and their implications in therapeutic approaches.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:54.451639+00:00"}
{"study_id": 110585, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the clinical utility of individualizing dual antiplatelet therapy (DAPT) guided by multiple electrode aggregometry (MEA), including assessing high on-treatment platelet reactivity (HPR) to arachidonic acid (AA)-induced aggregation.", "results_summary": "The study found that HPR to AA occurred in 9% of patients, with a higher proportion in those with HPR to ADP, and was treated with aspirin reloading. Definite stent thrombosis and other adverse events were minimal, suggesting effective management of AA-induced aggregation.", "population_specificity": "1008 consecutive PCI patients with stent implantation, including acute coronary syndrome (9% STEMI, 44% non-ST-elevation).", "effective_dosage": "Not specified (treatment guided by MEA thresholds: AA-induced aggregation >35 U).", "study_duration": "30-day follow-up for primary endpoints.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:54.637695+00:00"}
{"study_id": 110589, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the safety profiles of drugs (indomethacin, ibuprofen, and paracetamol) that inhibit arachidonic acid conversion to prostaglandins for managing PDA in preterm infants.", "results_summary": "The abstract highlights that ibuprofen has a higher safety profile than indomethacin, with fewer gastrointestinal and renal side effects, while paracetamol may be a promising alternative with low adverse events.", "population_specificity": "Preterm infants with patent ductus arteriosus (PDA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:55.745076+00:00"}
{"study_id": 110590, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of arachidonic acid-derived lipid mediators in modulating adipocyte metabolism and inflammation in white adipose tissue, particularly in the context of macrophage polarization.", "results_summary": "The study suggests that arachidonic acid-derived eicosanoids and endocannabinoids, along with other lipid mediators, play a role in adipose tissue inflammation and metabolic flexibility, with M2 macrophages potentially supporting healthier adipocyte function.", "population_specificity": "Mice (animal model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:56.698554+00:00"}
{"study_id": 110588, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare preoperative and postoperative platelet aggregation and activation, including arachidonic acid-induced aggregation, in congenital heart disease patients undergoing transcatheter closure of ASDs or VSDs, and to evaluate the appropriate aspirin dosage post-procedure.", "results_summary": "The study found that arachidonic acid-induced platelet aggregation significantly increased postoperatively but decreased after aspirin treatment (3 or 5 mg/kg/day). Both aspirin doses similarly reduced GMP-140 levels postoperatively, with no significant difference between doses.", "population_specificity": "32 congenital heart disease patients (16 ASD, 16 VSD; 13 males, 19 females; mean age 25.6\u00b19.15).", "effective_dosage": "3 mg/kg/day or 5 mg/kg/day enteric-coated aspirin.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:57.131590+00:00"}
{"study_id": 110591, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the roles of PGE2 and PGD2, derived from arachidonic acid, in brain pathophysiology and the impact of their efflux transport systems at brain barriers.", "results_summary": "The study found that PGE2 and PGD2 play key roles in brain function, with their levels regulated by efflux transport systems at the BBB and BCSFB. Dysfunction in these systems or inhibition by certain drugs (e.g., cephalosporins, NSAIDs) can adversely affect brain function and sleep regulation.", "population_specificity": "Mouse inflammation model (animal study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Cephalosporin antibiotics and nonsteroidal anti-inflammatory drugs inhibit PGE2 and PGD2 efflux transport.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:58.202451+00:00"}
{"study_id": 110592, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether clonidine affects platelet aggregability, specifically in the context of arachidonic acid-induced platelet aggregation (ASPItest), in patients on dual antiplatelet therapy.", "results_summary": "The study found no difference in platelet aggregation between clonidine-spiked and control samples in the ASPItest, indicating clonidine does not affect arachidonic acid-induced platelet aggregation. However, platelet aggregation in the ASPItest increased over time between blood drawing and analysis.", "population_specificity": "Patients treated with dual antiplatelet therapy (n=34).", "effective_dosage": "Not specified for arachidonic acid (clonidine dose: 1 ng/mL).", "study_duration": "Single time point (3 minutes post-spiking).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:58.670597+00:00"}
{"study_id": 110593, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between antithrombotic agents (including ASA, which affects arachidonic acid inhibition) and outcomes in traumatic brain injury, particularly intracranial hemorrhage and neurologic complications.", "results_summary": "The study found that arachidonic acid inhibition was higher in ASA patients compared to antithrombotic-negative patients, but intracranial hemorrhage rates and hemorrhagic-neurologic complications were similar between groups. Intracranial hemorrhage correlated with pre-existing brain atrophy, not antithrombotic use.", "population_specificity": "Patients aged \u226560 years with signs of external head trauma.", "effective_dosage": "Not specified", "study_duration": "Retrospective study (no intervention duration specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:01.965000+00:00"}
{"study_id": 110594, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether platelet function monitoring, including AA-induced IPA, could guide antiplatelet therapy to improve clinical outcomes in ACS patients undergoing high-risk PCI.", "results_summary": "The study found that AA-induced IPA was below 50% in 22.2% of patients, prompting aspirin dosage adjustment, but this monitoring did not significantly improve clinical outcomes compared to conventional therapy.", "population_specificity": "ACS patients who underwent high-risk, complex PCI (n=384).", "effective_dosage": "Aspirin dosage was raised to 200 mg/d if AA-induced IPA was <50%.", "study_duration": "Three months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:02.622477+00:00"}
{"study_id": 110596, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the biologic activity of cytochrome P450 (P450) enzymes, particularly focusing on metabolites derived from arachidonic acid, and their roles in inflammation, angiogenesis, and metabolic regulation.", "results_summary": "The study found that P450 enzymes generate bioactive lipid mediators from arachidonic acid, which play significant roles in inflammation, angiogenesis, and metabolic regulation. Additionally, inhibitors of soluble epoxide hydrolase, which modulate epoxide and diol levels, show potential for treating metabolic syndrome.", "population_specificity": "Not specified (likely preclinical or in vitro studies based on context).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:03.984196+00:00"}
{"study_id": 110595, "supplement_id": 885, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to examine the efficacy and safety of Arachidonic Acid (ARA) in treating school-age children infected with Schistosoma mansoni.", "results_summary": "ARA was as efficacious as praziquantel (PZQ) for low-intensity infections (78% vs. 85% cure rates) and, when combined with PZQ, achieved a 100% cure rate for moderate-intensity infections. Biochemical, hematological, and immunological parameters were either unchanged or improved after ARA therapy.", "population_specificity": "66 S. mansoni-infected schoolchildren (20-23 per study arm).", "effective_dosage": "10 mg/kg per day for ARA; 40 mg/kg single dose for PZQ.", "study_duration": "15 days for ARA.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:04.105979+00:00"}
{"study_id": 110600, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the mechanism by which CYP2J2 mutations impair arachidonic acid metabolism and its link to coronary artery disease.", "results_summary": "The study found that CYP2J2 mutations disrupt arachidonic acid metabolism by affecting key binding interactions, potentially contributing to coronary artery disease. The 3D structure analysis identified Gly486 and Leu378 as critical for ligand recognition.", "population_specificity": "Not specified (focused on molecular mechanisms).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:06.351418+00:00"}
{"study_id": 110597, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the postprandial clearance of omega-3 fatty acids, including arachidonic acid, in relation to APOE genotype, specifically comparing E4+ and E4- carriers.", "results_summary": "The study found a 2-fold higher ratio of EPA to arachidonic acid in E4+ carriers at fasting, suggesting potential genotype-dependent differences in fatty acid metabolism. Postprandial EPA levels were significantly reduced in E4+ subjects with high baseline EPA, indicating disrupted n-3 PUFA metabolism in this group.", "population_specificity": "11 E4+ (\u03f53/\u03f54) and 12 E4- (\u03f53/\u03f53) males from the SATgen\u03f5 study.", "effective_dosage": "3.45 g/d of docosahexaenoic acid (DHA).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:06.716043+00:00"}
{"study_id": 110598, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether platelet transfusion improves aspirin-induced platelet dysfunction, specifically in response to arachidonic acid (AA), in patients with traumatic intracranial hemorrhage.", "results_summary": "The study found that platelet transfusion improved aspirin-induced platelet dysfunction in response to AA (from 19.0 U to 26.0 U, P = 0.012), but not trauma-induced dysfunction. AA response was abnormal in aspirin-treated patients at admission but improved post-transfusion.", "population_specificity": "Patients with isolated traumatic intracranial hemorrhage, including 12 on aspirin therapy and 5 not on aspirin.", "effective_dosage": "Not specified (platelet transfusion involved one apheresis unit of platelets).", "study_duration": "Not specified (blood samples were taken at arrival and the next clinical laboratory draw after admission).", "interactions": "Aspirin (impaired AA response, improved by platelet transfusion).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:06.794688+00:00"}
{"study_id": 110599, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of arachidonic acid-triggered platelet aggregation in adjusting aspirin dosage for patients with a HeartMate II left ventricular assist device.", "results_summary": "Arachidonic acid-triggered platelet aggregation was used to titrate aspirin dosage, with 46% of patients requiring doses exceeding 160 mg/d to achieve aggregation below 20%. The study found no major improvements in thrombosis rates but noted reduced bleeding frequency.", "population_specificity": "Patients with a HeartMate II continuous-flow left ventricular assist device (n=24).", "effective_dosage": "Aspirin dosage was progressively increased until arachidonic acid-triggered platelet aggregation dropped below 20%; doses exceeded 160 mg/d in 46% of patients.", "study_duration": "Mean duration of support was 8.5 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:08.271975+00:00"}
{"study_id": 110602, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of arachidonic acid metabolism in pancreatic cancer progression and the potential of COX-2 and 5-LOX inhibitors as preventive agents.", "results_summary": "The study found that arachidonic acid metabolism via COX-2 and 5-LOX promotes pancreatic cancer cell proliferation, and blocking these enzymes reduces cancer cell growth in vitro and in vivo. COX-2 and 5-LOX are upregulated early in pancreatic cancer, suggesting their inhibitors could be effective as preventive agents.", "population_specificity": "Pancreatic cancer cell lines (in vitro) and patients with advanced pancreatic cancer (limited clinical data).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:10.984057+00:00"}
{"study_id": 110601, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the efficacy of a novel LC n-3 PUFA formulation (6:1-OM3) in correcting LC n-3 PUFA deficiency and its effects on lipid profiles, including the AA:EPA ratio.", "results_summary": "The study found that treatment with 6:1-OM3 significantly improved Omega-Score levels (132%) and reduced the AA:EPA ratio (82%). In hypertriglyceridemic subjects, it also improved HDL-C (9%), reduced TG (48%), and VLDL-C (30%) without significantly affecting LDL-C.", "population_specificity": "110 ambulatory cardiovascular subjects with LC n-3 PUFA deficiency.", "effective_dosage": "4 g/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:11.232017+00:00"}
{"study_id": 110603, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to explore the anti-inflammatory mechanisms and effects of omega-3 fatty acids (EPA and DHA) in comparison to arachidonic acid, focusing on their roles in inflammatory diseases.", "results_summary": "The study found that EPA and DHA inhibit several inflammatory processes linked to arachidonic acid, including eicosanoid production and cytokine expression, but clinical trials showed inconsistent efficacy in IBD and asthma.", "population_specificity": "Animal models and human clinical trials (rheumatoid arthritis, inflammatory bowel disease, asthma).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:11.841435+00:00"}
{"study_id": 110604, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate platelet function recovery after withdrawal and reintroduction of aspirin (using arachidonic acid as a marker) and clopidogrel in patients undergoing surgery.", "results_summary": "The study found that platelet function fully recovered 5 days after aspirin withdrawal, and reintroduction restored antiplatelet efficacy, as indicated by arachidonic acid-induced aggregation. Clopidogrel showed variable recovery and efficacy.", "population_specificity": "Consecutive patients taking aspirin or clopidogrel, and untreated controls (15 patients per group).", "effective_dosage": "Not specified", "study_duration": "5 days withdrawal before surgery, reintroduced 2 days post-surgery, assessed 5 days later.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:12.535425+00:00"}
{"study_id": 110607, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers explored associations between red blood cell membrane arachidonic acid content and inflammatory markers (TNF-\u03b1, IL-6, CRP) in young adults with low fish intake.", "results_summary": "Higher baseline levels of arachidonic acid were associated with increased TNF-\u03b1, suggesting a pro-inflammatory effect. No significant dose-response effect of EPA+DHA supplementation on inflammatory markers was observed.", "population_specificity": "Healthy young adults with low fish intake (n=116).", "effective_dosage": "Not applicable (arachidonic acid was measured, not supplemented).", "study_duration": "5 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:14.859954+00:00"}
{"study_id": 110606, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolism, particularly through COX-2 inhibition, in breast cancer therapy and its potential interactions with vitamin D metabolism.", "results_summary": "The study suggests that COX-2 inhibition, which affects arachidonic acid conversion to prostaglandins, has antiproliferative, prodifferentiation, and pro-apoptotic effects in malignancies, including breast cancer, and may synergize with vitamin D metabolites like calcitriol.", "population_specificity": "Patients with various malignancies, including breast cancer (in vitro, in vivo, and clinical trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effects noted with nonsteroidal anti-inflammatory drugs (NSAIDs) and calcitriol.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:15.625934+00:00"}
{"study_id": 110608, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of arachidonic acid (AA) in prostaglandin biosynthesis and its potential as a target for anti-inflammatory therapy.", "results_summary": "The study found that AA is converted into various prostaglandins, including PGE2, which mediates inflammation. Inhibiting AA metabolism via COX-2 or mPGES-1 could offer anti-inflammatory benefits with fewer side effects compared to nonselective NSAIDs.", "population_specificity": "Not specified (general human biology context).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:16.072280+00:00"}
{"study_id": 110605, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antiplatelet activity of hydroxychloroquine (HCQ) alone and in combination with aspirin (ASA) compared to ASA alone or ASA plus clopidogrel (CLOP), focusing on the arachidonic acid (AA) pathway.", "results_summary": "HCQ alone significantly reduced platelet aggregation when AA was used as an agonist. Combining HCQ with ASA showed a synergistic increase in inhibition of platelet aggregation compared to ASA alone, specifically through the AA pathway.", "population_specificity": "Healthy human volunteers (8 in part 1, 12 in part 2).", "effective_dosage": "Not specified in the abstract.", "study_duration": "7 days for HCQ alone; 14-day washout between treatment periods in part 2.", "interactions": "Synergistic effect noted with ASA, but no interactions with adenosine diphosphate or collagen.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:16.334233+00:00"}
{"study_id": 110609, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether midazolam, propofol, lidocaine, and magnesium interfere with MEA measurements using arachidonic acid as one of the platelet activators.", "results_summary": "The study found that midazolam, propofol, and lidocaine had no effect on MEA measurements with arachidonic acid, while magnesium showed significant interference with ADP and TRAP tests but not explicitly with arachidonic acid.", "population_specificity": "Twenty healthy volunteers.", "effective_dosage": "Not specified for arachidonic acid.", "study_duration": "Not specified.", "interactions": "None mentioned for arachidonic acid.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:19.485837+00:00"}
{"study_id": 110611, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of omega-3 highly unsaturated fatty acids (HUFAs) on neurodevelopmental outcomes and behavior, including aggression and antisocial behavior in youth and young adults.", "results_summary": "The meta-analysis found small to modest effects of omega-3 HUFAs in youth, while controlled trials combining omega-3 HUFAs with micronutrients showed sizable reductions in aggressive and violent behavior in young prisoners. However, studies on HUFAs in youth remain insufficient.", "population_specificity": "Youth and young adult prisoners.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:20.112060+00:00"}
{"study_id": 110610, "supplement_id": 885, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of arachidonic acid metabolism by CYP enzymes in the pathogenesis of ischemia-reperfusion injury and its potential as a therapeutic target for cardioprotection.", "results_summary": "The study found that certain CYP enzymes (e.g., CYP 2J2, CYP 2C8, CYP 2C9, CYP 4F) involved in arachidonic acid metabolism may contribute to ischemia-reperfusion injury, while mitochondrial CYP enzymes (e.g., CYP 11A1, CYP 27A1) could help preserve mitochondrial integrity by managing toxic oxysterols, suggesting potential therapeutic targets.", "population_specificity": "Not specified (focused on enzymatic pathways and theoretical cardioprotective mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:20.613170+00:00"}
